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Résumé 
Endocytose joue un rôle dans l'activation du récepteur Notch. Des mutations dans le 
gène drosophilien lethal giant discs (lgd), provoque une prolifération cellulaire en 
perturbant l’endocytose de Notch. Les orthologues murins mlgd1 et 2 peuvent sauver ce 
phénotype, démontrant une fonction conservée. Cependant, des publications récentes 
suggèrent que les orthologs humains de lgd (hgd1/2) sont nucléaires. Dans cette étude, il est 
démontré que chez la Drosophile, le mutant dlgd08 provoque l'accumulation de Notch dans 
des vésicules et une surprolifération de neuroblastes . Ceci suggère que Notch est activé a 
l'intérieur des endosomes dans les neuroblastes. L’immunohistochimie de cellules Hela 
indique que hlgd1 et 2 ne sont pas nucléaires, mais  associés à des strctures endosomales. 
Enfin, la baisse d’expression  par shRNA des gènes murins mlgd1 et mlgd2 provoque une 
différenciation accélérée des cellules souches hématopoïétiques dans la lignée 
lymphopoïèse T et bloque la transition DN3 / CD4+CD8+, suggérant une suractivation de 
Notch. 
 
Mots-clés : Endocytose, Notch, lethal giant discs (lgd), neuroblats, hématopoïèses, 
lymphopoïèse T 
iv 
 
Abstract 
Endocytosis plays a role in the activation of the Notch receptor. Mutations in the 
Drosophila gene lethal giant discs (lgd), causes cellular overgrowth by perturbing Notch 
endocytosis. This Drosophila phenotype is rescued by the murine orthologs mlgd1 and 2, 
indicating conserved function. However, recent publications suggest that the human 
orthologs (hlgd1/2) are nuclear. This study demonstrates that the dlgd08mutant in 
Drosophila causes accumulation of Notch in vesicles and the overproliferation of 
neuroblasts. This suggests Notch is activated from within endosomes in neuroblasts. 
Immunohistochemistry of Hela cells indicates that hlgd1 is associated with early endosome 
while, hlgd2 with later endosome and lysosome, and not with the nucleus. Finally, down 
regulation of murine mlgd1 and mlgd2 by shRNA caused an accelerated differentiation of 
hematopoietic stem cell into the T lymphopoiesis lineage and blocked the DN3 to 
CD4+CD8+ transition, suggesting that Notch is overactivated in these cells. 
 
Keywords : Endocytosis, Notch, lethal giant discs (lgd), neuroblasts, haematopoiesis,  T 
lymphopoiesis 
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1.1. Rationale of the current study 
Endocytosis is the process where cell surface receptors and soluble molecules 
present at the plasma membrane or in the extracellular medium are internalized into 
intracellular compartments. It has been demonstrated that endocytosis can regulate 
numerous processes, including: nutrient uptake, receptor signalling[1], cell adhesion and 
migration[2], cell polarity[3], pathogen entry[4], antigen presentation[5], 
neurotransmission[6], mitosis[7], growth and differentiation[8], and drug delivery. The 
Notch signalling cascade has been shown to be regulated by endocytosis.  The 
transmembrane Notch receptor has been demonstrated involved in cell fate specification in 
every animal species studied so far[9]. Notch signalling is essential to many developmental 
processes; this includes haematopoiesis[10], neurogenesis[11], and vasculogenesis[12] in 
mammals. It also regulates stem cell self-renewal, cell proliferation, cell differentiation and 
apoptosis. Loss of function of various components of the Notch signalling pathway causes 
inherited genetic diseases such as Alagille syndrome, spondylocostal dysostosis (SCD), and 
cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL)[13]. Notch is also a known oncogene and tumour 
suppressor in mammals[14, 15]. In human, mutations in one of the Notch homolog 
(NOTCH1) are involved in 50% of T-Cell Acute Lymphoblastic Leukemia (T-ALL)[16]. 
Levels of the different Notch isoforms have been shown to be increased in almost all T-
ALL. Growth arrest occurs in several T-ALL derived cell lines when Notch signalling is 
blocked, suggesting that modulating Notch activity may be a potent treatment strategy for 
some cancers[17]. 
      Notch signalling is regulated at numerous levels. The Notch receptor itself 
undergoes a series of modification to insure proper response to the different ligands (Delta 
and Serrate in Drosophila and Delta-like and Jagged in mammals) and activation[18]. The 
expression and activities of the ligands are also tightly regulated. It has been demonstrated 
that endocytosis is necessary both in the signal-receiving cell and in the signal sending cell.  
Endocytosis of the ligands seems to produce a force on Notch that allows its photolytic 
cleavage by an ADAM-like proteases at the plasma membrane[19, 20]. This leads to 
another cleavage by presenilin which occurs most-likely in endosomes[21, 22]. 
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Furthermore, Notch has been shown to be downregulated in some cells by Numb, a protein 
that recruits the AP-2 adaptor complex, which in turn recruits clathrin and causes 
endocytosis of Notch[23, 24]. In some Notch expressing tissues, the absence of Numb can 
induce an accumulation of the receptor at the cell surface and an overactivation of Notch. 
This can lead to an overproliferation of cells and a tumour-like growth of tissues[25, 26]. 
Surprisingly, accumulation of Notch in endocytic compartments can also cause a Notch 
overactivation and overgrowth of proliferating tissues. For example, this is the case in 
Drosophila when the endocytic proteins vps25 or erupted (ept) are missing[27, 28]. 
Interestingly, ept is the homolog of the tumour susceptibility gene 101 (tsg101) that has 
been shown to be implicated in numerous types of human cancer[29-33]. Finally, in some 
circumstances, Notch can also be activated through a ligand-independent mechanism. 
Accumulation of Notch in endosomes could favour this unusual mechanism[34-36].  
The Drosophila gene lethal giant discs (lgd), named after its loss of function 
phenotype has been shown to play a role in the regulation of the Notch signalling. 
Mutations in this gene cause overgrowth of the imaginal discs through a perturbation in 
Notch endocytosis[37-40]. The mammalian homologs of lgd are named CC2D1A and B or 
Freud-1 and -2 or mLgd1 and 2. For homogeneity, the Drosophila Lgd will be named dLgd, 
the mouse homologs respectively mLgd1 and 2 and the human homologs hLgd1 and 2. 
Though dLgd has been characterized to function in the endocytic pathway, its 
precise function is unknown. Even less is known of the mammalian lgd1 and 2. In a 
Drosophila loss-of-function experiment, both mlgd1 and 2 were able to rescue the dlgd 
loss-of-function phenotype, thus demonstrating a conservation of function between 
homologs[39]. However, recent publications suggest that they may act differently in 
mammals than in Drosophila[41-44]. In mammals, published data shows or strongly 
suggest that the Lgd homologs are not endocytic proteins but nuclear[41, 43, 44].
 The aim of this study was to determine the role of the Drosophila and mammalian 
Lgd in the endocytic pathway and to verify the conservation of its function in mammals.  
The literature review below provides a brief overview on the various forms of 
endocytosis and the role of endocytosis on Notch signalling. The role of Notch signalling in 
the hematopoietic system, brain and cancer development will also be looked at. A synopsis 
on what is known on Drosophila and mammalian Lgd will conclude this section. 
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1.2. Endocytosis 
The plasma membrane is a dynamic structure that segregates the intracellular milieu 
(the cytoplasm) from the extracellular environment. It regulates and coordinates the entry 
and exit of small and large molecules from the cell. Small molecules, such as amino acids, 
sugars and ions, can pass through the plasma membrane via passive diffusion or through 
the action of integral membrane protein pumps or channels. The process of invagination 
and pinching-off of pieces of the plasma membrane, known as endocytosis, is needed to 
internalize macromolecules in membrane bound vesicles into the cell. There are multiple 
forms of endocytosis which can be place into two broad categories, ‘phagocytosis’ or cell 
eating (the uptake of large particles) and ‘pinocytosis’ or cell drinking (the uptake of fluid 
and solutes)[45]. Phagocytosis usually occurs in specialized mammalian cells such as 
macrophages, monocytes and neutrophils that function to clear large pathogens like 
bacteria, yeast, or large debris such as the remnants of dead cells and arterial deposits of 
fat[46, 47]. Pinocytosis occurs in all cells by at least one of four basic mechanisms: 
macropinocytosis, clathrin-mediated endocytosis (CME), caveolae-mediated endocytosis, 
and clathrin- and caveolae-independent endocytosis[45]. These mechanistically diverse and 
highly regulated endocytic pathways function to control such complex physiological 
processes as nutrient uptake, receptor signalling[1], cell adhesion and migration[2], cell 
polarity[3], pathogen entry[4], antigen presentation[5], neurotransmission[6], mitosis[7], 
growth and differentiation[8], and drug delivery. 
 
1.2.1. Clathrin-Mediated Endocytosis 
Clathrin-dependent endocytosis is the major pathway for the uptake of nutrients and 
signalling molecules in higher eukaryotic cells. The formation of endocytic-coated vesicles 
start by the recruitment of clathrin, adaptors and endocytic accessory proteins to the plasma 
membrane where they form lipid-rafts ranging from 10 to 500 nm in diameter[48]. Proteins 
to be endocytosed are linked to the plasma membrane by coat proteins that bind both 
phosphatidylinositol(4,5)bisphosphate (PtdIns-4,5-P2), which is the prevalent 
phosphoinositide species of the plasma membrane, and transmembrane cargo[49]. There 
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Figure 1: Different types of endocytosis.  Transmission and scanning electron 
micrographs, and fluorescence micrographs, of structures known or thought to be involved 
in endocytic events. This figure was modified from Doherty and McMahon (2009)[50]. 
Note that there is controversy surrounding the morphologies of the IL2Rβ pathway and 
Arf6-dependent pathway. The arrowheads in the macropinocytic picture indicate 
cytoskeletal elements. 
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are four types of internalization signals identified located in the cytoplasmic tails of 
transmembrane proteins that are recognized by the endocytic adaptor proteins: the YXXΦ-, 
the [DE]XXXL[LI]-, the FXNPXY-type internalization signals and polyubiquitination. 
These signals are recognized by two types of endocytic adaptor proteins: the tetrameric 
adaptor-protein-2 (AP-2) and the monomeric adaptors ARH (autosomal recessive 
hypercholesterolemia protein), Dab2, β-arrestin, numb and epsin[51, 52]. Most adaptors are 
able to bind clathrin and the monomeric adaptors can also associate with AP-2. These 
adaptors are targeted to the plasma membrane through a phosphoinositide binding modules 
that associate preferentially with PtdIns-4,5-P2[49]. The AP-2 adaptor plays a central role 
since it can associate with most endocytic proteins[53]. The loss-of-function of AP-2 
subunits was proven to be lethal in Drosophila, C. Elegans and mice[54-56]. Also siRNA 
or RNAi mediated knockdown of AP-2 expression in HeLa cells eliminates about 90% of 
the endocytic clathrin-coated structures and blocks transferring uptake[57, 58]. However, 
even in the absence of AP-2 the Dab2 and epsin adaptors continue to mediate the uptake of 
LDL[58] and ubiquitinated cargo[59], respectively. These observations suggest that 
clathrin-mediated endocytosis can occur without AP-2. 
There are several ways of bending a membrane which includes the enrichment of 
cone-shaped lipids in the cytoplasmic leaflet of the membrane, insertion of protein into the 
cytoplasmic leaflet, binding of coat proteins with intrinsic curvature, and force exerted by 
the cytoskeleton[60]. The presence of clathrin and AP-2 was demonstrated to be essential 
for the invagination of coated structures, however it is not sufficient[61]. Members of the 
ENTH, BAR and EFC/F-BAR protein families have been shown to induce, sense and 
stabilize membrane curvature. For example, upon binding to PtdIns-4,5-P2 Epsin inserts a 
short amphipathic helix into the cytoplasmic leaflet of the plasma membrane thus bending 
the bilayer. Transient over-expression of the epsin ENTH domains cause tubular membrane 
structures in cultured cells[62]. However, when clathrin is depleted in HeLa cells, the 
presence of epsin and AP-2 is not sufficient to induce curvature[61]. This may be due to a 
requirement of clathrin for epsin to be able to curve the membrane or epsin may not be 
present in sufficient concentrations to bend the plasma membrane in the clathrin-deficient 
Hela cells. Depletion by RNAi of epsin in HeLa cells does not impede clathrin-dependent 
endocytosis of transferring but interfere with the uptake of ubiquitinated cargo[59]. 
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It is thought that the clathrin lattice induces, directly or indirectly, changes in the 
curvature of coated membrane patches by its inherent property to form a curved polyhedral 
network. It is theorized that synergistic contributions obtained from interactions between 
adaptors and clathrin, and from proteins within the cytosolic membrane leaflet are required 
to effective bend the membrane. The elastic spring-like linkage between the clathrin lattice 
and the membrane might allow for local changes in the curvature of either the membrane or 
the clathrin lattice without too much resistance by the respective other. In order to convert 
the hexagonal facets of clathrin into pentagonal ones clathrin needs to associate with local 
promoter to increase the lattice curvature. There is evidence that the uncoating ATPase 
Hsc70 and its co-chaperone GAK/auxilin7 may be involved in this process. It has been 
demonstrated that low levels of GAK/auxilin [63] and of the 170 Kda isoform of 
synaptojanin-1 (SJ1), a phosphatidylinositol phosphatise, are recruited together with 
clathrin in growing coated patches at the plasma membrane[64].  
The first event leading to scission and the release of a coated vesicle into the 
cytoplasm is the recruitment of dynamin GTPase. This most-likely occurs through 
curvature-sensing proteins[63, 65, 66]. Then cortactin, N-WASP, Arp2/3, actin, endophilin 
and the 145 kD isoform of Sj1 are recruited[64, 67]. GAK/auxilin is recruited in a short 
burst afterward[63]. The accessory protein HIP1/R, which is recruited together with 
clathrin into growing coated structures, connects the clathrin coat to actin filaments[68].  
 There are two theories on how these actin filaments help in scission of the coated 
vesicle into the cytoplasm. 1) The formation of actin filaments at the constricted neck of the 
budding vesicle may push the bud deeper into the cytoplasm and the increasing strain on 
the stalk may cause it to sever[49]. 2) Recent findings implicate the involvement of actin 
motor proteins in endocytosis. Myosin VI was shown to attach to coated vesicles through to 
the accessory protein Dab2 and PtdIns-4,5-P2 [69] and myosin 1E to dynamin and SJ1 
through its SH3 domain[70]. So it is thought that the plus-end motor myosin 1E may pull 
the dynamin ring toward the plasma membrane while the minus-end motor myosin VI pulls 
the vesicle into the cytoplasm. The strain produced from these opposing forces would sever 
the constricted stalk beneath the dynamin ring[49]. 
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Figure 2: Clathrin (A) and Caveolin (B) mediated vesicles. A) Diagram of the assembly 
and abscission of clathrin coated pits taken from Ungewickell & Hinrichsen, 2007[49]. The 
adaptor proteins, in this case AP-2, interact with both cargo protein and the cathrin lattice. 
Both the insertion of certain adaptor proteins into the membrane and the clathrin lattice help 
bends the membrane into the cell. Constriction of the vesicle neck by dynamin and 
additional pulling force provided by myosin motor proteins allow for vesicle fusion. B) 
Diagram of a caveola taken from Parton et al., 2007[71]. It demonstrates how caveolin is 
inserted into the caveolar membrane, with the N and C termini facing the cytoplasm and a 
putative ‘hairpin’ intramembrane domain embedded within the membrane bilayer. The 
scaffolding domain, a highly conserved region of caveolin, might have a role in cholesterol 
interactions through conserved basic (+) and bulky hydrophobic residues (red circles). The 
C-terminal domain, which is close to the intramembrane domain, is modified by palmitoyl 
groups that insert into the lipid bilayer.  
 
A) B) 
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1.2.2. Ubiquitin-Regulated endocytosis 
Ubiquitination is a reversible, post-translational modification that is the result of the 
conjugation of small 76 amino acids ubiquitin (Ub) protein to a lysine residue on a target 
protein.[72, 73] Ubiquitin itself can be ubiquitinated on one of its 7 lysines and polymerize 
into either short chains (oligoubiquitination) or longer chains (polyubiquitination). The 
length and the topology of these chains determine the fate of the ubiquitylated protein. 
Modification of a protein by ubiquitin (Ub) can cause a remodelling of the targeted protein 
by affecting their stability, interaction with other proteins, enzymatic activity, and their 
subcellular localization[72, 73]. 
Successive action of the ubiquitin-activating enzyme (E1), ubiquitin-conjugating 
enzyme (E2) and ubiquitin-protein ligase (E3) is required for ubiquitylation of proteins. 
Based on structural features, E3s can be classified into two categories: 1) the E3s with a 
RING domain (Really Interesting New Gene), which act as molecular scaffolds to bridge 
the E2 and substrates together to allow the transfer of ubiquitin, and 2) the E3s with a 
HECT domain (Homologous to E6-AP C-Terminus), where the ubiquitin moiety is first 
covalently attaches to the E3 before it is transferred onto the substrate[72, 73]. Both E3s 
dictating the specificity of the ubiquitylation reaction since they usually interact directly 
with the substrate. 
The Nedd4/Rsp5p family of ubiquitin-protein ligases regulate the stability of several 
yeast and mammalian transmembrane proteins by ubiquitination, and targets them for 
subsequent endocytosis.  The Nedd4/Rsp5p family belongs to the Hect-domain superfamily 
of E3 enzymes. They are all composed of a variable N terminus, a C2 domain, 2 to 4 WW 
domains and a C-terminal Hect domain[74]. The C2 domain binds phospholipids and 
membranes in a Ca2+-dependent manner and plays a role in membrane targeting, 
intracellular localization and trafficking of proteins[75]. The WW (or WWP) domain is a 
small (~40 aa) protein-protein interaction module that allows Nedd4/Rsp5 to form multiple 
interactions and complexes with various proteins simultaneously. It usually recognizes and 
ubiquinates proteins that contains a conserved PPxY motif. 
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Once targeted plasma membrane proteins are ubiquitinated, they are recognized by 
Ub binding domains (UBDs) containing proteins such as the endocytic adaptors eps15 or 
epsin[76]. The ubiquitinated proteins are then endocytosed in a clathrin-dependent manner. 
 
1.2.3    Caveolae-dependent endocytosis 
Caveolae, which are flask-shaped invaginations of around 60–80 nm in diameter, 
are found in many mammalian cells including in smooth muscle, type I pneumocytes, 
fibroblasts, adipocytes, and endothelial cells[71]. Caveolin-1 (Cav1) and Cav2 are abundant 
in non-muscle cells, while Cav3 is found in skeletal muscle and in some smooth-muscle 
cells[77]. Transient expression of Cav1 is sufficient for de novo formation of caveolae in 
cells that do not express caveolin[78]. Ablation of CAV1 or CAV3 causes loss of caveolae 
formation in their respective cell types[79, 80]. Loss of CAV2 has no effect on caveola 
formation in vivo however there is some evidence that it may contribute to caveola 
formation in certain cell types[81]. All three caveolins have an unusual topology. They 
have a 33-amino acid intramembrane that forms a hairpin loop that inserts into the plasma 
membrane which leaves the N and C terminals in the cytoplasm[82]. Caveola formation by 
Cav1 and Cav3 involves oligomerization and association with cholesterol-rich lipid-raft 
domains. Cav1 binds to 1–2 cholesterol molecules[83] and is also palmitoylated in the C-
terminal region[84]. The depletion of cholesterol has been demonstrated to disrupt caveolae 
structure[85]. Cav1 has been shown to bind the fatty acid tails of the glycosphingolipid 
(GSL) GM1 and can colocalize with GM1 and another “raft-associated” GSL, Gb3, in 
cellular membranes[86]. Caveolae endocytosis is dependent on dynamin. In endothelial 
cells dynamin is constitutively localized to the neck of caveolae[87], or is recruited in 
response to specific signals, such as stimulation by the SV40 virus[88]. The SV40 virus 
enters the cell partially through caveolae. It binds to GM1 and causes a transient 
recruitment of dynamin, which is followed by a burst of actin polymerization. The actin 
forms a tail that pushes the caveolae into the cell[88]. This sequence of events is similar to 
that observed in clathrin endocytosis. 
Phosphorylation appears to play an important part in caveolae budding. It has been 
shown that the use of the general phosphatase inhibitor okadaic acid and the tyrosine 
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phosphatase inhibitor vanadate can stimulate caveolae internalization[88, 89]. However in 
contrast, the Src family of kinases has been demonstrated to be able to phosphorylate both 
Cav1 and dynamin and that phosporylation of dynamin is directly involved in caveolae 
internalization[88, 90]. Thus, the precise role of these phosphorylations is presently 
unclear. 
 
1.2.4. The Early endosome 
The early endosome (EE) is the first endocytic compartment to receive incoming 
internalized cargo from the plasma membrane. It is a highly dynamic structure that can 
undergo homotypic fusion[91]. The EE is composed of two distinct regions: 1) thin tubular 
extensions and 2) large vesicles that have membrane invaginations. These EE sub-domains 
appear to have different function. It is thought that proteins targeted for recycling may 
cluster within the tubular membranes, while proteins destined for degradation concentrates 
on intralumenal vesicles that accumulate within the vacuolar domains, giving rise to 
multivesicular bodies (MVBs)[92]. Vesicles generated from these two regions have 
different acidification properties. In the lumen of MVB, the pH decreases from 6.2 to ~5.5, 
while in the tubular recycling endosomes it increases to ~6.5[92].  
The Ras-associated binding (Rab) proteins are GTP-binding proteins that are 
important endocytic regulators. In their active GTP-bound state, they can recruit and 
interact with Rab effectors. The Rab proteins have multiple roles in endocytic trafficking 
events, including vesicle tethering, fusion, budding and motility[93, 94]. The Rab proteins 
primarily localized to the EE include Rab5 and Rab4, which regulate distinct early 
endocytic events. Rab5’s main role is to regulate entry of the cargo from the plasma 
membrane and subsequent fusion of vesicles with early endosomes[95, 96]. Rab5 has 
multiple secondary functions as well, which include: generation of phosphotidylinositol-3-
phosphate (PtdIns-3-P) lipid which is enriched on EE[97], homotypic fusion[98],  the 
motility of EE on actin and microtubules tracks[99], and functions in activating signalling 
pathways from EE[100]. Rab4 is localized in the EE[101] and in Rab11-positive recycling 
endosomes (RE)[102] as well. It helps regulates both rapid recycling of proteins from the 
EE and the slow recycling of proteins from the RE back to the cell surface[103]. 
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Phospholipids play a role in recruiting proteins to specific domains of the EE. 
Active Rab5 recruits PtdIns-3-P kinase/Vps34 to EE membranes where it mediates 
localized synthesis of PtdIns-3-P[97]. This localized accumulation of PtdIns-3-P can recruit 
PtdIns-3-P-binding proteins containing a FYVE domain, such as EEA1 or Hrs, and 
containing PX domain, like Syntaxin 1[104, 105]. The recruitment of EEA1 can cause the 
homotypic fusion between EE through the assembly of SNAREs Syntaxin13 and Syntaxin6 
at the EE membranes[106]. While the recruitment of Hrs is essential for the sorting of 
ubiquitinated proteins into MVBs, which are then targeted for lysosomal degradation. 
 
1.2.5. The recycling endosome  
Upon delivery to EE, internalized cargo can be sorted into one of at least two 
distinct recycling pathways. Proteins sorted into the newly formed tubular membranes of 
the EE are recycled back directly to the plasma membrane. In parallel with tubulation, Rab4 
targets proteins to the recycling endosome (RE) where they proceed via a 'slow-recycling' 
route back to the plasma membrane[107].  
Rab4 has been identified to also be involved in the fast recycling of transferrin 
receptor[108] and glycosphingolipids[109] from the EE. However its exact role in recycling 
is unclear for expression of dominant-negative Rab4 inhibits fast recycling but not slow 
recycling and siRNA-mediated down-regulation of Rab4 increases rapid recycling[107, 
108]. Recent studies have indicated that Rab35 is an important regulator of rapid recycling. 
Rab35 has been shown to localize both at the plasma membrane and EE, and to be required 
for rapid recycling of the mammalian transferrin receptor[110] and the C. elegans low-
density lipoprotein receptor-like yolk receptor[111]. 
The slow recycling route involves the transport of cargo proteins from the EE to the 
RE and from the RE to the plasma membrane. The EH domain-containing protein (EHD) 
proteins appear to play many roles in the RE. EHD4 is involved in the export of cargo from 
the early endosome to both the RE and late endosome[112], while EHD3 act as linker 
between the Rab5-associated early endosome and the Rab11-associated RE. It can bind to 
the Asn–Pro–Phe motifs of the Rab5 effectors rabenosyn and Rab11 family-interacting 
protein 2 (Rab11FIP2)[113].  Rab11FIP5, another Rab11 effector, is important in the 
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movement of transferrin receptor from the EE to the RE. SiRNA down-regulation of 
Rab11FIP5 inhibits the transport of transferrin receptor from the early endosome to the 
RE[114]. Rab11FIP3 interacts with both Rab11 and Arf6 and is important for the 
juxtanuclear positioning of the RE[115].  
The sorting nexins protein in yeast, and its mammalian ortholog, sorting nexin 4 
(SNX4), associate with tubular vesicular elements on the both EE and RE, and target cargo 
for the recycling pathway. SNX4 interacts with the dynein motor through the linker protein 
WW domain-containing protein 1 (WWC1), facilitating the movement of the EE or RE to 
the juxtanuclear region[116]. Down-regulation of SNX4 perturbs transport between these 
compartments and causes lysosomal degradation of the transferrin receptor[116].  
 
1.2.6. The ESCRT complex and sorting for the 
lysosomal degradation 
Mono-ubiquitination of one or more lysine residues of endocytosed cargo serves as 
recruiting signal for the endosomal sorting complex for transport (ESCRT) 
machinery[117]. The ESCRT machinery has three main functions: 1) it recognizes 
ubiquitylated cargoes and prevents their recycling and/or retrograde trafficking; 2) it 
deforms the endosomal membrane allowing cargo to be sorted into endosomal 
invaginations; 3) it catalyses the final abscission (breaking off) of the endosomal 
invaginations, forming intralumenal vesicles (ILVs) that contain the sorted cargo[118]. The 
hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs), a member of the 
ESCRT-0 complex, is first recruited to the EE through binding of its FYVE zinc-finger 
domain to PtdIns-3-P[105]. Mono-ubiquitinated cargo on the EE is initially recognized by 
Hrs via its ubiquitin interacting motif (UIM)[105]. Hrs can also associates with clathrin 
through its C-terminal clathrin box motif. Hrs has been found on clathrin lattices present on 
select EE membranes involved in the sorting of cargo to the degradation pathway[118]. 
Binding of Hrs to ubiquitin and clathrin results in the concentration and sorting of cargo 
into ILVs vesicles, thus away from the tubule-forming and actively recycling membranes. 
However, Hrs binds to ubiquitin with a low affinity[105, 119], thus two additional UIM-
 
 
14
containing proteins make up the ESCRT-0 complex. Eps15 and signal transducing adaptor 
molecule (STAM) 1 and 2, stabilize the association of ubiquitinated cargo with Hrs[120]. 
Furthermore, Hrs interacts with the Tsg101 subunit of the endosomal sorting complex 
required for transport (ESCRT-I), thus recruiting it to membranes[120].  
ESCRT-I is composed of four subunits: tumour susceptibility gene (Tsg) 101, 
vacuolar protein sorting (Vps) 28, Vps37 and multi-vesicular body sorting factor 
(Mvb)12[121, 122]. The ESCRT-I complex is recruited to the endosome through the 
interaction of the amino acid motif proline, serine, alanine, and proline (PSAP) of Hrs with 
the ubiquitin-conjugating E2 variant (UEV) domains of Tsg101[123]. It is believed that the 
ubiquitinated cargo is then handed off from Hrs to Tsg101, which also contains a 
UIM[123]. ESCRT-II is recruited by Vps28, which is located at the end of a rigid 13-nm 
stalk opposite to the binding sites for ubiquitinated cargo[124]. With such a distance 
between the ubiquinated cargo and the ESCRT-II complex, it argues against the ‘conveyor 
belt’ concept. This concept was first suggested in a study by Babst, M. et al, 2002 and 
supported by subsequent studies on ESCRT proteins. This model states that the recruitment 
of the ESCRT complexes occurs sequentially to the endosome. The ESCRT complexes 
recognize ubiquitylated transmembrane proteins and pass the ubiquinated cargo from one 
complex to the next facilitating sorting to MVB vesicles[125]. It is thought that ESCRT-I 
and ESCRT-II may co-assemble and cluster multiple ubiquitinated proteins for packaging 
into ILVs[124]. ESCRT-II is composed of Vps22, Vps36 and Vps25. The c-terminal 
domain of Vps28 binds to the N-terminus of the Vps36. The N-termini of Vps36 also 
contains a pleckstrin homology (PH) domain variant called a ‘GLUE’ domain. This GLUE 
domain binds to both phosphoinositides and ubiquitin[126]. There are six ESCRT-III core 
proteins in yeast, Vps2, Vps20, Vps24, Snf7, Did2, and Vps60. Vps20 is first recruited to 
the endosome and activated by Vps25[127]. It forms dimers with Snf7 and associates with 
Vps32. This association with Vps20 triggers the assembly of Vps32 into filamentous 
oligomers that are capped by Vps24[128]. Vps2 then associates with the Vps24 cap to 
mediate recruitment of the ATPase Vps4[128]. The ESCRT-III subcomplex of Did2 and 
Vps60 recruitments and regulates the activity of Vps4[129]. 
There is some evidence of ESCRT-mediated membrane deformation obtained with 
ESCRT-III. Overexpression of the ESCRT-III subunit Vps32 in COS-7 cells caused the 
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formation of spiral filaments composed of Vps32 multimers, which lead to the protrusion 
of buds and tubules from the plasma membrane[130]. The topology and diameter of the 
buds and tubules on the plasma membrane resemble those of ILVs, suggesting that Vps32-
mediated plasma-membrane budding reflects key aspects of ILV biogenesis[130]. They are 
several lines of evidences suggesting that Tsg101 and one of its interacting partners, Alix 
(apoptosis-linked gene-2 (AGL-2) interacting protein X), are also involved in membrane 
deformation and intralumenal vesicles budding. The proline-rich domain located at the c-
terminal of Alix interacts with Tsg101. Addition of purified recombinant Alix inhibits 
formation of intralumenal vesicles in the late endosomes in a dose-dependent manner while 
siRNAs depletion of Alix stimulated formation of intralumenal vesicles[131]. The reverse 
was observed when Tsg101 was knocked down by siRNA[131]. Alix was also found to 
interact with the phospholipid lysobisphosphatidic acid (LBPA), which is commonly found 
within the internal membranes of late endosomes. It was demonstrated that Alix controls 
LBPA’s ability to drive the formation of membrane invaginations within acidic liposomes 
in vitro and helps organize LBPA-containing endosomes in vivo[132]. Recent studies done 
in Hela cells have identified the PtdIns-3-P-binding protein SNX3 as to be involved in ILV 
biogenesis.  Depletion of SNX3 by RNAi prevents ILV biogenesis but not receptor sorting, 
indicating that it has a specific role in membrane deformation[133].  
Abscission is thought to be mediated through the ATP hydrolyse activity of the 
ESCRT-III complex protein Vps4. The ESCRT-III subunits assemble into circular arrays 
on the LE. It is thought that Vps4-mediated removal of individual Vps32 subunits from one 
end of the spiral polymer at the neck of the invagination could cause sufficient constriction 
to mediate membrane scission[134]. It is also possible that ESCRT-III mediated clustering 
of cargo with bulky intraluminal domains could also contribute to both membrane 
deformation and abscission. Released MVB are transported and fused to the lysosome in a 
rab-7 dependent manner[135]. 
 
1.3. Notch signalling 
The transmembrane Notch receptor was named in the early 1900s after a dominant 
X-linked Drosophila genetic mutants that exhibit irregular notches at the wing tips [136, 
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137]. However, it wasn’t until the 1940s that Notch was shown to have a developmental 
role when complete loss of Notch gene activity was found to cause lethal hyperplasia of the 
embryonic nervous system[138]. Today it has been demonstrated that Notch signalling is 
essential to many developmental processes; this includes hematopoiesis[10], 
neurogenesis[11], and vasculogenesis[12] in mammals. It is involved in cell fate 
specification in every animal species studied so far[9]. Notch also regulates stem cell self-
renewal, cell proliferation, cell differentiation and apoptosis. Loss of function of various 
components of the Notch signalling pathway causes inherited genetic diseases such as 
Alagille syndrome, spondylocostal dysostosis (SCD), and cerebral autosomal dominant 
arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)[13]. Notch is 
also a known oncogene and tumour suppressor in mammals[14, 15]. Notch signalling can 
be either oncogenic or antiproliferative, in different types of cancers. In human 
hepatocellular carcinoma[139] and small cell lung cancer[140], Notch signalling is 
antiproliferative rather than oncogenic. However, studies have shown that Notch mostly 
functions as oncogene in human cancers. The expression of the Notch receptor and its 
ligans are up-regulated in cervical, lung, colon, head and neck, renal carcinoma, acute 
myeloid, Hodgkin and large-cell lymphomas and pancreatic cancer (as reviewed in [141]). 
Moreover, high-level expression of Notch-1 and its ligand Jagged-1 is associated with poor 
prognosis in breast[142] and prostate cancer. 
Notch signalling regulates cell fate decision (or differentiation) by three general 
mechanisms during both development and adult life: 
1) Inductive signalling occurs at the interface between two fields of cells, one of which 
is the signal-sending cell that presents the DSL family (Delta, Serrate and Lag 2) of Notch 
ligands to the signal-receiving cell that express the Notch receptor in neighbouring tissue. 
This type of interaction results in the formation of tissue boundaries, as is the case during 
fly wing and vertebrate limb development[143]. The dorsal/ventral boundary of the wing 
disc of drosophilas is formed by a stripe a few cell rows wide. In the dorsal cell, the Notch 
ligand Serrate is expressed and Notch is rendered insensitive to Serrate so that Serrate 
cannot activate Notch in these cells[144, 145]. Thus only the Notch receptor in the ventral 
cells across the boundary can be activated by Serrate. The reverse is true for the Notch 
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Delta ligand. Delta is expressed in the ventral cells, but can only activate Notch in the 
dorsal cells across the boundary[144, 145]. 
2) Lateral inhibition is the selection of one cell from a group of equivalent precursors. 
Initially all cells express both ligands and Notch receptor. However, as development 
progresses stochastic variations in gene expression cause small differences in Notch 
activation in the various cells so that in the end the ligand is restricted to a single cell while 
Notch is activated in its neighbours[143]. This can be seen in the equal spacing of sensory 
organs in the fly’s sensory bristles on the thorax and with the hair cells in the ear of 
vertebrates[146, 147].  
3) Asymmetric division occurs when a mother cell gives rise to two daughter cells with 
different fates. In some cases the two daughters are initially identical at birth and undergo 
the acquisition of different cell fate later on. Alternatively, the mother cell can become 
polarized and the two arising daughters receive different cell fate determinates at 
birth[148]. Stem cell epistatisi is thought to be regulated through this mechanism. When 
stem cells divide, one of the daughter cells retains stem cell status while the other daughter 
cell obtains cell fate determinates and differentiates. The dividing sensory organs precursor 
cells (SOP) is an excellent model system for asymmetric cell division, since the two 
resulting daughter cells receive different cell fate determinates[148]. The asymmetric 
division of SOPs yield two secondary precursor cells, the anterior cell, pIIb, and the 
posterior cell, pIIa. The pIIb receives cell fate determinants that activate the Delta ligand 
and down-regulate the Notch receptor, while the pIIa maintain an active Notch receptor at 
the plasma membrane[148, 149]. Activation of Notch signalling in the pIIa will gives rise 
to a socket cell and a hair cell, whereas the lack of Notch signalling in the pIIb will give 
rise to a neuron and a sheath cell[148, 149]. 
 
1.3.1. The role of endocytosis in Notch signalling 
The Notch receptor is synthesized as a 300 kDa precursor protein which is cleaved 
in the trans-Golgi compartment by furin in Drosophila and furin-like convertases in 
mammals. Cleavage occurs in the extracellular/lumenal domain which results in the 
generation of N- and C-terminal fragments. These fragments are joined by a non-covalent 
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linkage and create the mature Notch heterodimer[150, 151]. The extracellular cellular 
domain of Notch contains numerous potential sites for N-linked and O-linked glycosylation 
and does undergoes extensive N- and O-linked glycosylation during Notch synthesis and 
secretion[152, 153]. These modifications are important for proper folding of the receptor 
and alter the responsiveness to the different DSL ligands[152, 153], which includes Delta 
and Serrate in Drosophila, and Delta-like and Jagged in mammals. 
The canonical Notch signalling pathway (Figure 3.B.) involves activation of the 
Notch receptor at the cell surface by ligands of the DSL family. Both the Notch receptor 
and DSL ligands are composed mostly of type I single-pass integral membrane proteins 
with extracellular domains composed of tandem EGF-like repeats[154, 155]. The N-
terminal domain of the ligand binds directly to the EGF-like repeat 11-12 region of the 
Notch receptor[156]. The ligand on the surface of a signal-sending cell must be internalized 
to activate the Notch receptor on the signal-receiving cell[157]. The DSL ligands are 
endocytosed through recognition of a ubiquitination signal. Neuralized (Neur) and Mind 
bomb (Mib) are two RING finger-containing E3 ubiquitin ligases that can ubquitinate the 
DSL ligans[158, 159]. This promotes the recruitment of liquid facet in Drosophila, Epsins 
in mammal, which contain a ubiquitin-binding domain.  Espsin then binds the PtdIns-4,5-P2 
and associates with Clathrin and other accessory proteins[160] to induce clathrin-mediated 
endocytosis of the DSL ligans.  
It is thought that DSL ligands may undergo constitutive endocytosis and recycling 
to and from the plasma membrane to produce active ligands[159]. It has been demonstrated 
that following asymmetric cell division of SOPs in Drosophila, Delta is concentrated in 
recycling endosomes in pIIb cells. In loss of function studies, expression of either rab11 or 
sec15 mutants, which function together to recycle proteins back to the cell surface, produce 
cell-fate transformations to a phenotype consistent with loss of Notch signalling, which is 
thought to be due DSL ligand inactivity[161, 162]. 
When Notch from the signal-receiving cell associates with the DSL ligand from the 
signal-sending cell, the endocytosis of the ligand on the signal-sending cell, known as 
transendocytosis, induces a physical force on the Notch receptor on the signal receiving 
cell[20]. This force destabilizes the non-covalent bonds of the Notch heterodimers structure 
exposing the ADAM cleavage site and allowing for proteolytic activation of the Notch 
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receptor[20]. The S2 cleavage site is located in the extracellular portion of the Notch C-
terminal fragmen and is cleaved by the metalloproteases ADAM10/TACE in mammals, 
Kuzbanian in Drosophila, are responsible for t[163-165]. This S2 cleavage removes the 
ectodomain resulting in a membrane-anchored Notch form termed Notch extracellular 
truncation (NEXT).  
It is then believed that NEXT must first be endocytosed before it can undergo the γ-
secretase-mediated S3 cleavage in the transmembrane domain of the Notch receptor. The γ-
secretase activity is provided by the protease presenilin[166]. It has been demonstrated that 
inhibition of NEXT endocytosis by using dominant-negative forms of either Dynamin2 or 
Eps15 blocks γ-secretase processing of NEXT[167]. It was also found that NEXT can be 
monoubiquitinated at a conserved lysine residue, and mutation of this lysine reduced both 
NEXT internalization and S3 cleavage [167].  NEXT endocytosis may also be required for 
activated presenilin to have access to the S3-cleagave site. It is thought that biologically 
active presenilin pools are located in intracellular compartments. It has been shown that 
large pool of active presenilin complexes are found in lipid rafts within the endosomal 
pathway[168]. 
The transcription factors of the conserved mammalian CBF1/Drosophila Su(H)/C. 
elegans LAG-1 (CSL) family are the primary nuclear effectors of Notch signalling. In the 
absence of Notch activation, the CSL proteins act as transcriptional repressors with other 
known co-repressors on Notch target genes[169]. In Drosophila, CSL promotes the 
recruitment of the Asf1 histone chaperone to silence many Notch genes[170]. Upon γ-
secretase proteolytic cleavage by persenilin in the transmembrane domain of NEXT, the 
Notch intracellular domain (NICD) is released. The NICD fragment then translocate into 
the nucleus where it physically binds to CSL and, together with the co-activator 
Mastermind (Mam in Drosophila and mammals; LAG-3 in C. elegans), forming a 
transcriptionally active ternary complex[171, 172]. Once formed, the complex recruits 
general transcription factors, such as CBP/p300 and PCAF, and promotes chromatin 
acetylation and expression of the Notch target genes[173, 174].  
Once generated, the NICD signalling fragment can no longer be regulated by ligand 
binding or other cell-surface events. Disassembly of the CSL/NICD/Mam ternary complex 
and signal attenuation is mediated by ubiquitination and proteosomal degradation. NICD is 
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first phosphorylated by cyclin-dependent kinase 8 in its C-terminal PEST domain and then 
targeted for degradation by the E3 ubiquitin ligase Fbw7 in mammals and SEL-10 in C. 
elegans[175, 176]. It is important to tightly controlled NICD turnover to prevent sustained 
signalling for an inappropriately long period or at an excessively high level. It has been 
shown that some cases of T-ALL have mutations that delete the Notch PEST domain, 
which lead to an inability to degrade NICD properly[177]. 
The Notch receptor can also be targeted for lysomal degradation through 
ubiquitination directly from the plasma membrane. The E3 ubiquitin ligases Suppressor of 
deltex (Drosophila), Itch (mammals), SEL-10 (C. elegans)[178], and Cbl (Drosophila and 
mammals)[179], have been identified that target non-activated Notch for degradation[36, 
180]. Numb is a conserved membrane-associated protein that acts upstream of the γ-
secretase cleavage to block Notch signalling[23]. In 3T3 cell culture assay, Numb was 
shown to interact with Itch to promote Itch-dependent ubiquitinylation, endocytosis and 
degradation of Notch1[181]. Numb interacts with both Notch and AP-2, thus helping to 
recruit the components of the clathrin-dependent endocytosis pathway to internalize the 
Notch receptor[23, 24]. In some Notch expressing tissues, the absence of Numb can induce 
an accumulation of the receptor at the cell surface and an overactivation of Notch. This can 
lead to an overproliferation of cells and a tumour-like growth of tissues[25, 26].  
 Ubiquitination of the Notch receptor can also act positively on Notch signalling and 
influence the endosome trafficking of the Notch receptor[182] (Figure 3.C.). Deltex (dx), 
an E3 ubiquitin ligase containing a RING domain, has been shown to physically associate 
with Notch and the β-arrestin, Kurtz in Drosophila, promoting internalization of the whole 
complex[183]. Loss-of-function of dx has no affect on mutant fly viability and fertility, 
however Notch-like patterning defects were observed, suggesting that in some tissues 
Notch signalling is activated in a Deltex-dependent manner[35]. Resent genetic studies on 
the Drosophila HOPS and AP-3 complexes revealed that they are required for Deltex-
dependent, ligand-independent Notch signalling[184]. They help deliver intact, non-ligand-
activated Notch to the limiting membrane of the lysosome. This leads to the accumulation 
of the Notch receptor, ectodomain shedding and/or degradation, and γ-secretase-mediated 
activation of the receptor[184].  The HOPS complex act in late endosome maturation and 
lysosomal fusion, while the AP-3 complex act in endosomal trafficking of proteins to the  
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Figure 3:  Models of Notch trafficking and activation in the endocytic pathway. a. 
Schematic representation of the main steps of the endocytic pathway. b. Schematic 
representation of the ligand dependent activation of Notch. Notch can be activated either at 
the plasma membrane or in the endosome. c. Schematic representation of the ligand-
independent activation of Notch.  
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limiting membrane of the lysosome. 
The ESCRT complex is another component that acts in ubiquitin-dependent 
endosomal sorting pathway that influence Notch signalling. Drosophila mutant cells for 
either ept, the drosophila homolog of tsg101, or vps25, two components of the ESCRT-I 
complex, undergo autonomous neoplastic transformation and also non-autonomous cell 
proliferation. This is due mostly to the activation of the Notch receptor that induces 
hyperproliferation of mutant cells as well as adjacent wild-type cells[27, 28, 185]. An 
increase of Notch signalling in mutant cells leads to the ectopic production of Unpaired, a 
ligand that activates the mitogenic JAK-STAT pathway in neighbouring wild-type 
epithelial cells. The Notch receptor accumulates in enlarged endosomes in ept and vps25 
mutant cells resulting in increased activation of Notch signalling[27, 28, 185]. RNAi 
knockdown of vps25 in Drosophila S2 cells increased S3 cleavage of Notch receptor by 
presenilin, an effect that was inhibited with the use of a presenilin inhibitor[185].  
 
1.3.2. Notch and the hematopoietic system 
During mouse embryogenesis, primitive hematopoiesis arise from mesodermal 
precursors, known as hemangioblasts, that migrate and become committed to endothelial 
and hematopoietic progenitors in the yolk sac blood island at embryonic day 7.5 
(E7.5)[186].  Primitive hematopoiesis primarily consists of nucleated erythrocytes with 
embryonic-type globin. Hematopoiesis gradually shifts to the fatal liver after E11.5 and 
later to spleen and bone marrow[186]. Hematopoietic progenitors and lymphopoietic cells 
that will give rise to adult-type blood cells are detected in the paraaortic splanchnopleura 
region of mouse embryo at E7.5–9.5[187, 188]. The long-term repopulating hematopoietic 
stem cells (LTR-HSCs) that can reconstitute the adult mice hematopoietic system originates 
from the intraembryonic aorta, gonads, and mesonephros (AGM) region at E10.5–
11.5[189-191]. In the adult mouse LTR-HSC can self-renew and give rise to short-term 
HSCs. These ST-HSCs self-renew for a short period of time and eventually give rises to 
non-selfrenewing multipotent progenitors (MPPs). Over time the MMPs lose their 
multipotent capacities and they become either common myeloid progenitors[192] or 
common lymphoid progenitors[193]. Common lymphoid progenitors (CLP) can 
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differentiate into B, T, natural killer and dendritic cells[193]. The common myeloid 
progenitors can mature to give rise to two other sets of progenitors: the 
granulocyte/macrophage progenitors and the megakaryocyte/erythrocyte progenitors[192]. 
Recently, circulating T cell progenitors has been identified in blood, suggesting that 
commitment toward the T cell lineage can occur extrathymically[194, 195].  
The major progenitor source that enters the T cell pathway in adult mice is the 
lymphoid primed multipotent progenitors (LMPPs) found in both the bone marrow and 
peripheral blood. These cells can give rise to macrophages, dendritic cells, natural killer 
cells, B cells and T cells, but not erythrocytes or megakaryocytes[196, 197]. These cells 
migrate to the thymus, where the LMPPs are exposed to various factors that triggers and 
supports pro-T cell differentiation, proliferation and survival[198]. The earliest described 
intrathymic progenitors and are the early T-cells/thymic progenitors (ETPs), which are also 
known as CD4–CD8– double-Negative 1 (DN1) cells. When sorted by flow cytometry (table 
1) ETPs display a Lin–Sca1+c-kithigh+CD24lo/+CD25–CD44+ surface phenotype[199, 200]. 
At this stage, DN1 retain a weak potential to differentiate into the B lineage potential both 
in vivo and in vitro, however they still have the ability to differentiate into natural killer 
cells and some dendritic and myeloid cells[201, 202].  DN2s (c-kit+DC44+CD25+) retains 
some potential to differentiate into lineages other then T-cells[201]. True commitment to T 
lineage occurs only at the DN3 (CD44-CD25+) stage after completion of pre-T cell receptor 
(TCR) β rearrangement is completed (DN4) (figure 4) [203]. The TCR is specific to T cell 
and is expressed at the cell surface. It is generally responsible for recognizing antigens 
bound to major histocompatibility complex. DN4 then become mature CD4+CD8+ double-
positive (DP) T cells. These DP T cells go on to differentiate into different subset of T 
cells, single positive (SP) CD4+ or CD8+ T cells[204]. 
The implication of Notch in the hematopoietic system was first discovered though 
the identification that Notch plays a critical function of in T lineage development.  Neonatal 
mice that expressed a loss of function Notch1 had a severe deficiency in thymocyte 
development[205]. Also, in competitive repopulation of lethally irradiated wild-type mice 
bone marrow with wild-type- and Notch1-deficient bone marrow, a blockage in T cell 
development was observed at an early stage[205].  In a concurrent experiment, when the 
constitutively active form of Notch1 was expressed to reconstitute irradiated bone marrow, 
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the repopulated bone marrow was mostly composed of immature CD4+ CD8+ T cells and 
there appeared to be a simultaneous block in early B cell lymphopoiesis[206]. At the time, 
these results suggested that Notch1 was a key regulator in determining T lymphoid versus 
B lymphoid lineage[205, 206]. Subsequent studies have demonstrated that Notch signalling 
is important in many hematopoietic lineages and plays essential roles at several stages of T 
cell development, differentiation and function, including during T cell immune 
responses[207-209].  Notch signalling was also shown to be essential for the generation of 
foetal hematopoietic stem cells (HSCs), but appears dispensable for the maintenance of 
adult HSCs[210, 211]. 
Over the past decade, it has been demonstrated that Notch1 is a critical player in 
committing hematopoietic progenitors to the T cell fate. Common lymphoid precursors 
(CLP)s deficient for Notch1 develop into B cells[207, 213] and dendritic cells[214], while 
overexpression of Notch1 in common lymphoid precursors drive T cell development at 
expense of natural killer and B lymphoid cells[207], and the myeloid lineage[215]. Notch1 
interacts specifically with Delta-like-4 (Dl4), which is expressed at high levels in thymic 
epithelial cells[216]. T cell development can be studied in vitro using a two-dimensional 
cultures system where hematopoietic progenitors are exposed to Delta-like ligands that are 
either coated on the plate or expressed by cells[212-214]. OP9 cells are a macrophage 
colony stimulating factor-deficient bone marrow stromal cell line that can support 
lymphoid lineage differentiation. Mouse foetal liver, bone marrow HSCs and embryonic 
stem cells, as well as human cord blood and bone marrow cells co-cultured on top of OP9 
cells transduced with the Notch ligand Delta-like-1 (OP9-Dl1) cells supports T 
lymphopoiesis, while having a dose-dependent negative impact on B, natural killer, and 
monocytic/dendritic cell generation[215]. It has been demonstrated that in hematopoietic 
progenitors, Notch1signalling acts through the canonical CSL and Mam pathway to activate 
transcription[216, 217]. Progenitors cultured with ligands of the Jagged family are not 
driven to a particular pathway and thus develop into all hematopoietic lineages[213, 214]. 
Notch signalling intensity is carefully regulated throughout T cell development and 
differentiation (Figure 4). Notch signalling is maintained a very low level in primitive 
hematopoietic progenitors located in the bone marrow. In the bone marrow Notch 
signalling is inhibited by the transcriptional repressor Leukemia/lymphoma-Related Factor  
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Markers Type of Cell Lineage Day of measurement                 
(relative to the first day in culture) 
Lin–Sca1+c-cithigh+ 
CD24lo/+CD25–CD44+ 
ETPs (LSK-like) B and T-cells Day 0, 5 and 12 
c-kit+ CD25+ DC44+ DN2  T-cells Day 5 
c-kit- CD25+ DC44– DN3  T-cells Day 5 and 12 
CD4+ CD8+ DP  T-cells Day 12 
CD4+ CD8- TCRβ+/ 
CD4- CD8+ TCRβ+ 
SP  T-cells Day 12 
B220+ CD19- pre-pro-B  B-cells  Day 5 
B220+ CD19+ pro-B to 
mature B-cells 
B-cells  Day 12 
CD11b+ Monocytes Monocytes Days 5 and 12  
NK1.1+ Natural killer 
cells 
Natural killer 
cells 
Days 5 and 12 
 
Table 1: In vitro lymphopoiesis of HMCs by OP-9 co-culture and flow cytometry 
markers used to identify the different lineages 
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Figure 4: Notch signalling in T- and B-cell development. In the thymus, Notch1 (N1) in 
thymus-seeding progenitors (TSPs), which are most commonly lymphoid primed 
multipotent progenitors (LMPPs),  interacts with Delta-like 4 (Dll4) on thymic epithelium 
to suppress their B-cell potential and promote T-lineage specification. N1 also suppresses 
myeloid (M/G), dendritic cell (DC), and NK-cell fates at the early T-cell precursor (ETP) 
and double-negative 2 (DN2) stages, but the Notch ligand required for this suppression in 
vivo has not been identified. N1 also regulates survival prior to β-selection, and then 
cooperates with pre-T-cell receptor (TCR) signalling to promote survival and proliferation 
during the DN3 to double positive (DP) transition. Figure adapted from Stanley, P. and 
Guidos, C.J., 2009[218]. 
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(LRF)[219]. Knockout of LRF in hematopoietic progenitor bone marrow cells in mice was 
embryonic lethal due to severe anaemia. When these bone marrow LRF-negative cells were 
expanded in a co-culture system, the cells were no longer able differentiate into B cell, 
however they retain their ability to differentiate into T cell[219]. In a bone marrow 
repopulation assays, LRF-negative progenitor cells were unable to repopulate B cell linage 
cells in the peripheral blood, while the T cell population was relative normal compared to 
wild-type. Abnormally, lost of LRF in the bone marrow progenitors lead to extrathymic 
development of T cells in the bone marrow[219]. These experiments demonstrated that 
LRF acts in a cell-autonomous manner on hematopoietic progenitors, without altering 
Notch ligand expression in the bone marrow microenvironment[219].  
The exact role Notch signalling in DN1-DN2 transition is ambiguous, however 
Notch signalling is required for the maintenance of CD25 expression in DN2 and DN3 cells 
and the survival of DN2, DN3 and DN4 cells[220, 221]. Notch signalling is maintained in 
mice until the β selection or pre-TCR checkpoint (Figure 4). Though Notch signalling is 
required for transition from DN4 to CD4+CD8+ double-positive (DP) cells, it is rapidly 
downregulated afterwards by pre-TCR signalling mechanisms[222, 223]. There are 
different subtypes of the TCR receptors. Mature T cells that select for the TCRαβ recognise 
peptidic antigens bound to major histocompatibility complex (MHC) proteins[224] and 
selection of which peptidic antigens the T cell will recognise occurs prior to leaving the 
thymus. Antigen selection for mature TCRγδ T cells occurs in the peripheral blood oppose 
as in the thymus. These TCRγδ T cells can be triggered to produce cytokines in their naïve 
state and do not require the MHC molecules for antigen selection[225]. In mice, selection 
for αβ over γδ T cell lineage is dependent on Notch signalling[203, 226]. The opposite is 
true in humans. High levels of Notch activation favour the γδ T cell lineage over the αβ T 
cell lineage[227].  
The role of Notch signalling in the selection of mature signal positive (SP) CD4+ or 
CD8+ cells is controversial with gain- and loss-of-function experiments being at odds with 
one another. When the constitutive active form of Notch (NICD) was expressed in mice, 
decreased CD4+ and increased CD8+ SP thymocyte was observed[228]. However, when 
endogenous Notch signalling was inhibited in thymocytes, little or no effect on CD4+ and 
CD8+ SP development was seen[228]. Modulation of the downstream Notch effectors, such 
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as conditional deletion of CSL[229] or induction of a dominant negative form of 
Mastermind[230], in mice produced normal SP thymocytes. However when deleting 
Presenilin1/2, the mice show impaired SP thymocyte development[231]. Discrepancies 
between these results could be due to differential temporal expression of the various 
proteins. The gene deletion of Presenilin1 is initiated at the DN2-DN3 stage, thus occurs 
prior to TCRβ selection[231]. This severely impacts DP thymocyte number because the 
cells cannot mature past the DN3 stage[203, 232]. In these experiments, the deletion of the 
CSL gene is induced later, at the DP stage[231], while the mutant mastermind is not 
expressed until the DP stage. The fact that CSL and mastermind deficient thymocytes 
generate normal numbers of DP thymocytes [229, 230] indicates that Notch signalling is 
down regulated later, most likely after TCRβ selection. 
Notch signalling and intensity must be careful regulated, since deregulation of 
Notch activation in T cells can give rise to T cell leukemia, both experimentally and in 
patients[233]. Notch was first implicated in T-ALL when a rare t(7:9) translocation 
between the TCRβ promoter/enhancer sequences and the genomic region encoding the 
NOTCH1 intracellular domain was discovered[16]. Since then, activating NOTCH1 point 
mutations have been described to occur in 50% of T-ALL cases[177].  
 
1.3.3. Asymmetric cell division and Notch  
Signalling 
Asymmetric cell division (ACD) is crucial for generating diversity. The underlying 
mechanisms of ACD has emerged over the past decade from studies performed in 
Drosophila melanogaster and Caenorhabditis elegans (figure 5). Asymmetric division 
occurs when a mother cell gives rise to two daughter cells with different fates. In some 
cases the two daughters are initially identical at birth and undergo the acquisition of 
different cell fate later on. Alternatively, the mother cell can become polarized and the two 
arising daughters receive different cell fate determinates at birth[148]. This is the case for 
dividing sensory organs precursor cells (SOP).  
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1.3.3.1. Asymmetric cell division of sensory 
organs precursor cells (SOP) 
The asymmetric division of SOPs yield two secondary precursor cells, the anterior 
cell, pIIb, and the posterior cell, pIIa. Cell fate specification comes from directional 
signalling between the two cells, where the Delta ligand secreted from the pIIb cell 
activates the Notch receptor on pIIa cells, thus initiating different transcriptional cell fate 
programmes in the two cells. For example, the mRNA of the transcriptional repressor 
tramtrack p69 (TTK69), is originally present in both cells[234, 235]. However, ttk69 
translation is prevented in pIIb by the RNA-binding protein Musashi.  In pIIa cells, Notch 
signalling prevents Musashi-dependent translational repression of ttk69, thus in the end, 
TTK69 is only present in pIIa cells[234, 235]. Another cell fate programs is the association 
of the activated NICD signalling fragment of the Notch receptor with Suppressor of 
Hairless to form a transcriptional activator complex in pIIa cells[236].   
Originally Delta and Notch are expressed in both pIIb and pIIa. Directional 
signalling from pIIb towards pIIa is in part established through the asymmetric distribution 
Numb and Neuralized (Neur). During mitosis Numb co-localizes with Pins–Gαi at the 
anterior cortex of SOPs and thus is partitioned into pIIb[237, 238]. In numb mutants, two 
pIIa-like cells are generated giving rise to a Notch over expression phenotype, while 
overexpression of numb yields two pIIb-like cells that have Notch downregulation 
phenotype[239]. Numb associates with α-Adaptin, a component of the AP-2 complex that 
targets transmembrane proteins for endocytosis[23, 24]. Sanpodo, a transmembrane protein 
known to associates with Numb and to be implicated in Notch signalling[240], appears to 
also be involved in α-adaptin-mediated endocytosis[241]. In wild-type cells Sanpodo is 
present at the cell membrane of pIIa and localizes on endosomes in pIIb. In numb or α-
adaptin mutants Sanpodo is no longer endocytosed and found at the plasma membrane of 
both pIIa and pIIb cells[241]. The E3 ubiquitin ligase Neur also regulates signalling 
between the pIIb and pIIa cells. Neur localizes at the anterior cortex of SOPs during mitosis 
and is inherited only by the pIIb[242]. Neur mutants inherit a Notch loss-of-function 
phenotype, thus indicating that Neur is needed for pIIa fate acquisition. Neur can 
monoubiquitylate Delta and promote its endocytosis into pIIb[242, 243].  
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The asymmetric distribution of Numb and Neur, while important, does not fully 
explain why signalling occurs only from pIIb towards pIIa. Differential distribution of the 
recycling endosome functions redundantly with Numb and Neur asymmetry[161]. The 
recycling endosome, which is marked by the GTPase Rab11, is found throughout pIIa. 
However, in pIIb cells, the recycling endosome is found clustered around the centrosome 
along with its binding partner, the Arfophilin homologue Nuclear fallout (Nuf)[161]. This 
clustering of the recycling endosome is believed promotes endocytosis and activation of 
Delta in the pIIb cells. Overexpression of nuf causes Rab11 clustering in pIIa. However 
simultaneous overexpression of nuf and the non-phosphorylatable form of Lethal (2) giant 
larvae (lgl-3A), is needed to observed dramatic changes in cell-fate. Lgl is a cytoskeletal 
protein that recruits cell fate determinates to the cortex. When it is phosphorylated by 
aPKC, it dissociates from the actin cytoskeleton and excludes Numb and Neur from the 
posterior part of dividing SOPs[244]. Thus these results indicate that differential 
distribution of the recycling endosome functions in parallel with Numb and Neur 
asymmetry[161]. 
 
1.3.3.2. Asymmetric cell division of neuroblast 
During Drosophila embryogenesis, neuroblasts originate from the neuroectoderm, a 
monolayer of epithelial cells, through a process of lateral inhibition[245, 246]. Specified 
neuroblasts delaminate from the epithelium layer and enter mitosis. During prophase two 
centrosomes migrate laterally to opposite sides of the neuroblast and align parallel to the 
epithelium layer[245, 246]. At metaphase the mitotic spindle is oriented along the apical-
basal axis and upon cytokinesis, the neuroblast undergo asymmetric division that gives rise 
to a larger apical neuroblast and a smaller basal ganglion mother cell (GMC)[245, 246] 
(figure 5.b.). These two resulting daughter cells inherit different fates: the neuroblast can 
continue to divide asymmetrically and self-renew, whereas the GMC is committed to the 
differentiation pathway and divides terminally to produce two neurons or glial cells. 
The apical-basal polarity of an epithelial cell is established through the 
evolutionarily conserved Par protein complex consisting of Bazooka (Baz, the fly homolog  
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Figure 5: Asymmetric cell division in worms and flies. This figure depicting asymmetric 
division in one-cell Caenorhabditis elegans embryos (a), Drosophila melanogaster larval 
neuroblasts (b) and D. melanogaster sensory organ precursors (SOPs) (c) was taken from 
Gönczy, P., 2009[148]. The polarized mother cell during anaphase is shown at the top of 
each panel, while the resulting daughter cells are shown at the bottom. The distribution of 
important components for the establishment of polarity; spindle positioning and cell-fate 
determination is illustrated for the mother cell, and the distribution of cell-fate determinants 
is shown for daughter cells. Furthermore, directional signalling between the anterior cell 
(pIIb) and the posterior cell (pIIa), whereby the Delta ligand from pIIb signals to the Notch 
receptor on pIIa, is denoted by a thick arrow in panel c. GMC, ganglion mother cell; Mud, 
mushroom body defectice; NB, neuroblast. 
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of C. elegans Par-3), Par-6, and atypical PKC (aPKC) [245, 246]. When a neuroblast 
delaminates from the epithelium, it forms an apical stalk which remains in contact with the 
surrounding epithelial cells. The Par complex located in the apical stalk colocalizes with 
Inscuteable (Insc), a neuroblast-specific protein, and establishes the apical-basal polarity in 
the delaminating neuroblast[247-249].  During mitosis, the Insc/Par complex recruits a 
complex composed of Partner of Inscuteable (Pins) and the heterotrimeric G protein subunit 
Gαi to maintain apical-basal polarity at the apical cortex[250-252]. 
These two protein complexes have distinct roles. The Pins/Gαi complex is mainly 
involved in orienting the spindle perpendicular to the epithelium layer at metaphase[248, 
253], while the Par complex primary plays role in the basal localization of cell-fate 
determinants. The apical Par complex regulates Discs large (Dlg) and Lethal (2) giant 
larvae (Lgl), two cortically localized tumour suppressors, to direct the basal localization 
and segregation of cell-fate determinants, such as Prospero (Pros) and Numb and their 
adaptor proteins, Miranda (Mira) and Partner of Numb (Pon)[244, 254, 255]. The PKinase 
aPKC inactivates Lgl by phosphorylation, thus preventing Lgl from associating with the 
apical cortex. However, phosphorylated Lgl can restrict myosin II activity to the apical 
cortex, resulting in expulsion of cell-fate determinants to the basal cortex[256]. In the basal 
cortex, Lgl is not phosophorylated and thus remains active and recruits cell-fate 
determinants to the basal cortex[244]. Myosin VI also positively regulates basal 
localization by recruiting Mira/Pros via vesicle transport machinery[257]. 
Notch signalling plays a role in regulating cell fate choice in the central nervous 
system. The selection of a single neuronal precursor from a cluster of equipotent 
progenitors that express the basic helix-loop-helix (bHLH) transcription factors, termed the 
proneural genes, is done through the Notch pathway. The expression of these proneural 
genes in the  ectoderm is both necessary and sufficient to initiate the development of 
neuronal lineages and to promote the generation of progenitors that are committed to 
differentiation[258]. In loss-of-function experiment, when Notch signalling is lost, the cells 
within the clusters retain expression of the proneural genes and become neural cells[259, 
260]. While the expression of the constitutively active form of Notch causes the cells 
within the cluster acquire an epidermal cell fate[261]. During the selection of neural 
precursors, in both Drosophila and vertebrates, the intracellular domain of Notch associates 
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with its co-activator Suppressor of Hairless (Su(H)) to elicits the transcriptional activation 
of the Enhancer of Split (E'(Spl)) family of bHLH transcriptional repressors. In turn, 
Enhancer of Split proteins repress the proneural genes[261-263]. This inhibition of 
proneural gene expression leads to the inhibition of a neuronal fate. 
The neural precursor gene asense (ase), has long been accepted to be expressed in 
all neuroblasts [264, 265] and is often used as a neuroblast marker during 
immunohistochemistry studies. A recent study identified eight neuroblasts per brain lobe 
that do not express the Ase protein, which were named Posterior Asense-Negative (PAN) 
neuroblasts[266]. Six of the PAN neuroblasts are located medially and divide 
asymmetrically to produce Ase- neuroblast and an Ase+ neuroblast. These Ase- neuroblast 
are usually surrounded by long chains of Ase+ progeny cells, typical Ase+ neuroblasts 
usually have a small number of closely associated Ase+ progeny[266]. The other two 
additional PAN neuroblasts generated progeny that populate interior brain regions[266]. 
The Ase+ progeny cells continue to amplify transiently and eventually differentiate into 
neurons or gila cells. 
It was found that expression of brat RNAi, a cell-fate determinant that is inherited 
in GMCs, causes defective differentiation in Ase+ progeny of PAN-neuroblasts leading to 
cellular overgrowth[266]. Further investigation demonstrated that this overproliferation was 
due to over deregulation of the Notch pathway. numb loss-of function mutant, lgd mutant 
or overexpression NICD causes phenotypes similar to the brat RNAi phenotype[266]. 
Knockdown of Notch by RNAi had two different effects on PAN-lineages: it either 
eliminated them entirely or reduced the number of associated Ase+ progeny[266]. These 
results suggest that Notch signalling is active and required for proper asymmetric division 
and differentiation in the PAN-neuroblast and the secondary Ase+ neuroblasts. However, 
overactivation of Notch causes uncontrolled division of Ase+ secondary neuroblasts[266].   
   
1.4. Notch and mammalian brain development 
The mammalian neocortex develops into a highly organized six layered structure at 
the anterior end of the neural tube. The first set of neural progenitor cells are found in the 
ventricular zone (VZ). After the onset of neurogenesis, a second germinal area, known as 
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the subventricular zone (SVZ), forms just below the VZ. Both the VZ and SVZ contain 
highly proliferative neural progenitors which can undergo symmetric and asymmetric cell 
divisions to either maintain the proliferative pool or produce the neurons of the different 
cortical layers[267]. Neurogenesis approximately begins at day 10.5 of embryogenesis 
(E10.5) in mice and lasts until around E17.5, when gliogenesis begins in the SVZ[268]. 
Newly produced neuronal progenitors in the VZ or SVZ migrate radially out of these zones 
along radial glia cells to the neocortical plate, where they differentiation and forms 
neuronal circuits[267, 269]. 
Evidence that Notch can inhibit neuronal differentiation in vertebrates was first seen 
in vitro study using embryonic carcinoma cell line P19 by Nye et al., 1994[270]. These 
cells can be induced to differentiate into neurons, astrocytes, or myoblasts under certain 
conditions[271-273] (figure 6.A). When Nye et al., 1994[270] stably transfected the murine 
full length Notch receptor or the active form, the NICD, into P19 cells, they inhibited the 
differentiation of the P19 cells into neurons and myoblasts[270]. However activation of 
Notch had no effects on astrocyte differentiation[270]. Since this initial study, the role of 
Notch signalling in the embryonic mammalian nervous system has been extensively 
investigated using both loss- and gain-of-function approaches.  
Mouse embryos expressing Notch1 mutants were found to be embryonic lethal. 
Homozygous mutant embryos died around 11.5E[274, 275]. Morphological and 
histological analysis of the homozygous mutant embryos indicated that pattern formation 
through the first nine days of gestation appeared largely normal.  However, mutant embryos 
at a later stage revealed widespread cell death[274, 275]. Detailed analysis of neuronal 
development of Notch1-/- mice was first carried by de la Pompa et al., 1997. They found 
that expression of either loss-of-function Notch or CSL caused reduced expression of the 
hes-5 target gene and an increase expression of Dl1[276]. They also found an up regulation 
of the early differentiating neurons markers Math4A, neuroD and NSCL-1 in the Notch1 
and CSL mutant embryos, demonstrating that there was an excess of committed neuronal 
precursors generated at 9.0E in the mutants[276]. 
Mice carrying nulls for the other Notch alleles were also made. Embryos 
homozygous for either the Notch3 or Notch4 mutant developed normally and homozygous 
mutant adults were viable and fertile[277, 278]. There were no detectable genetic 
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interactions during early embryogenesis between the Notch3 mutation and a targeted 
mutation of the Notch1 gene when double homozygous mutant embryos were made[278]. 
However, the Notch4 mutation displayed genetic interactions with a targeted mutation of 
the related Notch1 gene. Embryos homozygous for mutations of both mutants displayed a 
more severe phenotype than Notch1 homozygous mutant embryos[277]. Both Notch1 
mutant and Notch1/Notch4 double mutant embryos displayed severe defects in angiogenic 
vascular remodelling[277]. Notch2 homozygous mutant mice resemble Notch1 mutant 
mice the most. Notch2 deficient embryos die around 11.5E. Notch2 was found to be 
expressed in a wide variety of tissues including neuroepithelia, somites, optic vesicles, otic 
vesicles, and branchial arches, but not heart[279, 280]. Histological analysis of the mutant 
embryos showed earlier onset and higher incidence of apoptosis, particularly in neural 
tissues. However Notch2 mutant mice, in contrast to Notch1-deficient mice, do not show 
disorganized somitogenesis and the expression of the neurogenic genes such as Hes-5 or 
Mash1 remain unchanged[279].  
Retroviral expression of Notch1 in neuronal precursors at E14.5 inhibits the 
generation of neurons, delays the emergence of cells from the subventricular zone (SVZ), 
produces an augmentation of glial progeny and postnatal astrocytes[281, 282]. When these 
Notch+ neuronal progenitor cells were cultured for a short period of time, Notch1 inhibited 
their proliferation and caused a decrease in neuron generation (Figure 6.B)[281]. However 
in longer gliogenesis cultures, activated Notch1 triggered rapid cellular proliferation 
causing a significant increase in radial gial cell generation (Figure 6.B)[281]. Notch3 has 
been shown to be implicated in radial gial cell fate also. Retroviral infection at 9.5E of 
murin neuronal progenitors with the NICD3 promoted the generation of radial glial 
embryonically and astrocyte fate postnatally (Figure 6.B)[283]. Expression of an activated 
form of CBF1 (CBF1-VP16), a Notch effector, or of the Notch target gene, Hes5, also 
promotes radial glial cell fate in vivo[283]. This is very similar to what is seen in 
Drosophila neuronal development. Radial glia have their cell bodies in the VZ and extend 
radially to the pial surface, which cotes the surface of the cortex[284]. These cells are 
thought to provide a migratory scaffold along which newly generated neurons migrate from 
the VZ to postmitotic areas[285]. The migrating neurons express Notch ligands, such as 
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Delta. They promote radial glial identity by activating the Notch receptor expressed along 
radial glial fibbers[286]. 
 
1.5. The Drosophila l(2)giant discs (lgd) protein 
The l(2)giant discs (lgd) protein was first discovered in a mutagenesis screen and was 
named after its ability to causes massive overproliferation of imaginal disc cells when non-
functional[287]. This protein is evolutionary conserved and can be found from worms to 
mammals. However, it is not found in yeast[38]. Lgd encodes a 816 amino acid protein that 
contain four DM14 repeats of unknown function[288], three Lgd homology domains only 
found in this protein family, and a C-terminal C2 (Protein Kinase C conserved region 2) 
domain. C2 domains are known as calcium and lipid binding domains, and they are thought 
to have many functions such as protein-protein interaction, membrane recruitment, protein 
localization, and trafficking [289]. It was found that the lgd C2 domain binds preferentially 
to PI(3)P and PI(4)P, which are associated with the early endosomes and secretory 
vesicles[290], respectively, on a PIP strip suggesting that Lgd acts in the endocytic or 
secretory pathways[38]. 
Early characterization of lgd mutant wing discs found a deregulation of the wingless 
and decapentaplegic genes[291]. Wingless is one of the genes regulated by Notch at the 
dorso-ventral boundery during wing development. Notch over activation causes similar 
phenotypes as that of lgd mutants in the wing disc[292, 293] leading to speculation that the 
lgd mutant phenotype could stem from the ectopic activation of the Notch pathway. This 
was found to be indeed the case. Thomas Klein demonstrated that loss of lgd function leads 
to the ectopic expression of Notch target genes[40]. Ectopic expression of wingless and cell 
overproliferation was abolished in lgd and presenilin double mutant wing discs as well as 
in Suppressor of Hairless and lgd double mutants[39, 40]. These results indicated that 
presenilin acts upstream of lgd and that lgd helps in the processing of Notch. Later studies 
found that lgd mutant wing discs overgrowth was caused by cell autonomous ligand-
independent Notch activation[37, 39]. This was due to the accumulation of Notch in 
subcellular puncta labelled by Hrs, an early endosome marker, resulting in ectopic Notch 
signalling[37]. Lgd appears to function prior to the ESCRT complex since lgd and vps25  
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Figure 6: Notch signalling in the developing and adult central nervous system.  
A) Processes that are likely to involve pathway signalling are labelled 'Notch' (green), and 
those that are likely to require downregulation of Notch signalling are labelled 'Off' (red).  
B) Phenotype observed when isolated neuronal precursors that overexpress Notch1/3 are 
cultured. Figure was adapted from Yoon, K. and Gaiano, N., 2005[294]. 
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double mutants do not alter or enhance the lgd mutant phenotype. However, ectopic Notch 
activation is no longer seen in hrs and lgd double mutants suggesting that lgd functions 
downstream of hrs[37]. 
Expression of mutant lgd or overexpression of full length lgd, also leads to Notch 
over activation in SOP. Notch and Delta in pIIa and pIIb cells are found in enlarged 
vesicles positive for Hrs and Rab5, makers of the early endosome, when lgd is 
overexpressed[38]. Lgd mutants had no affect on effect on the size, shape, or distribution of 
the late endosome, recycling endosome and the exocyst complex, indicating that lgd 
functions in the early endosome[38]. Lgd appears to be required for general protein sorting 
since disruption of lgd function leads to not only an accumulation of Notch in enlarges 
early endosome punctas, but also of ubiquitinated protein and of the Drosophila EGF 
receptor[38, 39]. Recent studies done in the Drosophila wing disc, has demonstrated that 
the two murine orthologs of lgd can rescue the Drosophila lgd mutant and restricts the 
expression of wingless to its normal domain along the dorso-ventral boundary.[39] 
 
1.6. The mammalian lgd orthologs, coiled-coil and C2 
domain containing 1 (CC2D1) protein A and B 
Very little is known about the mammalian counterparts of lgd. The human 
CC2D1A, which will be referred as hlgd1, was first found to be involved in autosomal 
recessive inheritance of non-syndromic mental retardation (NSMR)[295, 296].  Mentally 
retarded individuals affected do not have major physical abnormalities, dysmorphism, or 
neurological abnormalities. It is thought that biological processes involved in neuronal 
differentiation, synaptic plasticity, synaptic vesicle cycling, and gene expression regulation 
are the causes of mental retardation[297]. Homozygosity mapping of individuals affected 
by NSMR of the same family identified a homozygous and haploidentical region of 2.4 Mb 
to 0.9 Mb on chromosome 19p13.12[295, 296]. Sequencing of the cDNA with various 
primers found different types of mutations. The first mutation mapped was the complete 
deletion of 3589 nucleotides beginning in intron 13 and ending in intron 16 of hlgd1 [295]. 
The deletion caused a frame shift immediately after the deletion, creating a nonsense 
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peptide of 30 aa and a stop codon at position 438 of the mutant protein[295]. The mutation 
caused a loss of the DM14 and C2 domains of the gene. Western blot analysis done in 
lymphoblastoid cells derived from patients using a CC2D1A antibody, which detected the 
N-terminus of the protein, identified a 104 kDa band in normal individuals but not in the 
patients[295]. Mapping done on another family found a splice mutation that result in the 
skipping of exon 19[296]. The splicing of exon 18 to exon 20 causes a frameshift, resulting 
in the addition of 13 nonsense amino acids after exon 18 and the addition of a premature 
stop codon. The protein is truncated after the amino acid 740 resulting in the lost of the C2 
domain[296].  
In situ hybridisation studies were done to examine spatial expression patterns of 
mlgd1 during murin brain development. It was observed that at E12 the mlgd1 mRNA was 
expressed throughout the ventricular zone, developing cortical plate and ganglionic 
eminences[295]. By E16, mlgd1 mRNA was expressed throughout the mouse brain, and 
was particularly expressed strongly in the cortical plate[295]. At postnatal day 3, mlgd1 
mRNA continued to be widely expressed with strong expression in the cerebral cortex and 
hippocampus[295]. The mlgd1 mRNA was expressed in the brain into adulthood[295]. 
Given the expression patterns of mlgd1 and that mutations in the hlgd1 gene leads to poorly 
differentiated neurons in NSMR, it appears that mammalian lgd is implicated in brain 
development. 
Subcellular localisation studies performed in the human osteosarcoma cell line 
U2OS using a polyclonal antibody for the hlgd1 protein, found that the protein was 
distributed throughout the cytoplasm and no signal was detected in the nuclei[295]. 
However, a study done by Ou, X.M. et al, 2003 suggest otherwise. In a yeast one-hybrid 
assay to find regulatory proteins that target the serotonin receptor (5-HT1A) dual repressor 
element (DRE) using a murin brain cDNA library, Ou, X.M. et al, 2003 identified mlgd1 as 
a transcription regulator for 5-HT1A[298]. In a luciferase assay using one of the DRE 
components, the 5’-repressor element, they demonstrated that over expression of mlgd1 
caused a decrease expression of the luciferase gene, while co-transfection with anti-sense 
cDNA increased the expression of the luciferase gene[298]. Western blot analysis of 5-
HT1A receptor protein levels mirror the results obtained in the luciferase assay. Protein 
levels of 5-HT1A decreased after transient transfection with sense mlgd1 and increased 
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when anti-sense mlgd1 was transfected[298]. Furthermore, immunofluorescent staining of 
cells in culture and rat brain sections, Ou, X.M. et al, 2003 showed that rat lgd1 (rlgd1) 
protein was present in the nucleus of cells. Cells that stained weakly for rlgd displayed 
stronger 5-HT1A staining, and vice-versa for cells expressing higher levels of rlgd1 [298]. 
This suggested that lgd1 protein inhibits the expression of the 5-HT1A receptor in vivo as 
well. The same group also showed that both human lgd othologs can also bind to the 5-
HT1A DRE and represses the human 5-HT1A receptor gene[41]. 
A recent study by Nakamra, A. et al, 2008 has implicated hlgd1 in the 
phosphoinositide 3-kinase (PI3K)/3-phosphoinositide-dependent protein kinase 1 
(PDK1)/Akt pathway. Using a HeLa cDNA library and a human foetal brain cDNA library 
they found that hlgd1 interacts with PDK1 in an E. Coli two-hybrid screen[42]. This 
interaction was confirmed in mammalian cells and co-immunoprecipitation studies with 
various hlgd1 deletion mutants found that that the region around the forth DM14 domain is 
needed for hlgd1 to bind PDK1[42]. Akt activity is correlated with its phosphorylation 
levels at the Thr308 and Ser473 residues. It was found that down regulation of hlgd1 
expression with siRNA causes a significant decrease in the levels of phospho-Thr308-Akt, 
but not Ser473[42]. GST pull-down analysis with in vitro-translated recombinant hlgd1 and 
Akt demonstrated that hlgd1 forms a complex with Akt and PDK1 and positively regulate 
PDK1-mediated Akt phosphorylation[42].  
Several growth factors trigger the activation of PI3K, which leads to Akt activation. 
EGF stimulation increased the phospho-Thr308-Akt levels. Knowdown of hlgd1 inhibits 
phosphorylation and activation of PDK1 induced by EGF stimulation[42]. It was found that 
hlgd1 could co-immunoprecipitate with the EGFR when cells were stimulated with 
EGF[42]. It was also demonstrated endogenous Akt and hlgd1 could form a complex upon 
EGF treatment, thus indicating that hlgd acts as a scaffold to form a multiprotein complex 
in response to EGF stimulation. In cooperation with PIP3, hlgd1 recruits the PDK1/Akt 
signalling module to the activated EGFR[42]. It was also demonstrated that down 
regulation of hlgd1 by siRNA causes increased cellular apoptosis and sensitivity to 
chemotherapeutic drugs[42]. These results indicate that hlgd1 is regulator of PDK1/Akt 
signalling in the maintenance of cell survival and cell proliferation. 
  
Materials and Methods 
 
 
42
2.1. Fly Strains 
Fly strains used were:  InscGal4; UAS CD8::GFP/cyo (gift from JA Knoblich, Institute 
of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria),  UAS 
Rab5QL/TM (gift from Marcos González-Gaitán, University of Geneva) , Ubx flp; lgd08 
FR40 tubE GFP/cyo (gift from JA Knoblich). Crosses were preformed and tansgenes were 
expressed at 25°C. 
 
2.2. Tissue staining and antibodies 
Third-instar larvae were selected and brains dissected in PBS (Bioshop, Burlington, 
Ontario, Canada), fixed in 5% paraformaldehyde (Bioshop) in PBS for 20 min, and blocked 
using 2% BSA (Invitrogen, Carlsbad, California, USA) in PBS with 0.05% Triton X-100 
(Bioshop) and 0.04% sodium azide (Bioshop). Brains were incubated with the primary 
antibody rat anti-Elav (1:300, Developmental Studies Hybridoma Bank (DSHB), Iowa 
City, Iowa, USA) guinea pig anti-Dpn (1:1000, gift from JB Skeath, Washington 
University School of Medicine, St Louis, Missouri, USA) and mouse anti-Notch 
intracellular domain (C17.9C6) (1:100, DSHB) overnight. Secondary antibodies used were 
anti-guinea IgG pig Alexa Fluor 555 (1:500, Invitrogen) and α-mouse CY5 (1:500, 
Invitrogen). Dapi (1:10000, Sigma-Aldrich, Oakville, Ontario, Canada) was used to stain 
nuclei. Brains were mounted in Mowiol 4-88 (Sigma-Aldrich). 
 
2.3. Cell culture 
The HEK-239T cells (Sigma-Aldrich), Hela (gift from PS Maddox, Université de 
Montréal, Montréal, Québec, Canada) and NIH-3T3 (gift from G. Sauvageau, Université de 
Montréal, Montréal, Québec, Canada) were maintained in Modified Eagle medium 
(DMEM) supplemented with 10% foetal bovine serum  (FBS), 100 U/mL penicillin and 
100μg/ mL streptomycin (all from Invitrogen). OP9-GFP and OP9-Dl1 (gifts from C. 
Perreault, Université de Montréal, Montréal, Québec, Canada) were maintained in α-
Minimal Eagle’s medium (α-MEM) (Invitrogen) supplemented with 20% (FBS), 100 U/mL 
penicillin, 100μg/ mL streptomycin and 2 mM L-glutamine (Sigma-Aldrich). 
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2.4. Endocytosis Assay 
Hela cells were plated onto 12 mm cover glass (VWR, Montreal, Quebec, Canada) at a 
density of 5x105 cells/mL. Cells were allowed to adhere to the cover glass overnight. To 
label the early and late endosomes, the cells were incubated with 3 mg/mL rhodamine-
dextran (10 KDa, Molecular probes-Invetrogen) for 15 or 45 minutes, respectively, at 37°C. 
Cells where then placed at 4°C, washed with PBS and fixed in 3% paraformaldehyde. Cells 
were permabilized with 0.1%  Saponin (Bioshop) and then incubated with the primary 
antibodies mouse anti-EEA1 (1:50, BD laboratories, Mississauga, Ontario, Canada), mouse 
anti-LAMP2 (ABL-93) (1:20, DSHB), mouse anti-hLgd1 (1:250, Abcam Inc., Cambridge, 
Massachusetts, USA) and rabbit anti-hLgd2 (1:250, Aviva Systems Biology, San Diego, 
California, USA). Secondary antibodies used were anti-rabbit IgG Alexa Fluor 488 (1:500, 
Invitrogen) and α-mouse CY5. Dapi (1:10000) was used to stain nuclei. The cover glasses 
were mounted using Mowiol 4-88 onto cover slides (WVR). 
 
2.5. Image acquisition 
Images from fixed tissues and cells were acquired using a LSM 510 META inverted 
confocal microscope (Zeiss, Toronto, Ontario, Canada) using either a 40x or a 63X 
objective. Images were acquired by sequential scans in multiple channels. For figure 
assembly, images were processed with Photoshop (Adobe, Ottawa, Ontario, Canada), using 
only the “Gaussian blur” and the “level” function. Quantifications of vesicles were 
performed on the original images using the Image J program (National Institutes of Health 
(NIH), Bethesda, Maryland, USA). 
 
2.6. Lentiviral production and infection 
Five short hairpin RNA (shRNA) sequences specific to the mLgd1 and mLgd2 were 
designed (sigma-Aldrich) and cloned into lentiviruses. 
 
mLgd1: 1) AGGCCCTAGAGAAACTGAAAG    mLgd2: 1) TGAGGATCGGGAAGAGATTTG 
             2) AGGGCAACATCATCAATGAAG                 2) ATCGCATTGCCAAGCAATATC 
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            3) ACTCCTAAGAAGCAGAATACC        3) GAGGCTCGGAAACTGCAATAC 
            4) TCCGCTTTGACTTCCCTTATC        4) ACCCTCCTAGTCATCACTTTG 
            5) GAGCGGCTAGAAAGGAAGATC        5) TGGCACAGCACACTTGAAATT 
 
Briefly, the viral packaging and RNA polymerase III promoter plasmids (pMD2-VSVG, 
pMDLg/pREE and pRSV-REV, gift from S. Meloche, Université de Montréal, Montréal, 
Québec, Canada) were co-transfected by calcium phosphatase (chemical for solution from 
Bioshop) with the shRNA sequences into HEK-239T. Viral soup was collected after 48 hrs 
and filtered (0.45 µm, VWR). A 7 day puromycine (1 µg/ml, Invitrogen) kill curve using 
Hela cells was done to determine the viral titter.  12 hours prior to infection, 50 000 NIH-
3T3 cells were plated in a 6-well plate. The medium was removed and replaced by the viral 
soup, calculated so that the multiplicity of infection (MOI) is 25. 7 μg/mL of polybrene 
(Invitrogen) was also added to the viral soup and cells were incubated for 36 hours. Cells 
were then transferred to a 10 cm dish and cells were challenged with puromycine (1 µg/ml) 
for 4 days for selection of cells expressing the lentiviruses. 
 
2.7. RNA extraction, reverse transcription and RT-qPCR 
Total RNA was isolated with TRIzol reagent (Invitrogen) according to the 
manufacturer's instructions. Purified RNA was reversed transcribed using SuperScript™ II 
Reverse Transcriptase (Invitrogen) with random primers (Applied Biosystems) as described 
by the manufacturer. Expression level of target genes was determined using primer and 
probe sets from Universal ProbeLibrary: https://www.roche-applied-
science.com/sis/rtpcr/upl/index.jsp.  
Primer sequences are: mLgd1forward- gcctctcgcaatggactg, reverse-
gcaccagcacaaagtcgtc; mLgd2 forward-ccagggtgctgagactgc, reverse-agcatgtcctcagggttgaa. 
Pre-developed TaqMan® assays for Hptr were used as endogenous controls. RT-qPCR 
analyses were performed as described using a PRISM® 7900 HT Sequence Detection 
System (Applied Biosystems, Streetsville, Ontario, Canada). The relative quantification of 
target genes was determined by using the ΔΔCT (cycle threshold) method. Relative 
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expression (RQ) was calculated using the Sequence Detection System (SDS) 2.2.2 software 
(Applied Biosystems) and the formula RQ = 2-ΔΔCT. 
 
2.8. Western blot 
Cells were harvested and lysed in NP-40 lysis buffer (Sigma-Aldrich). The lysates were 
cleared by centrifugation and the protein content was measured by the Bradford method 
(Biorad, Mississauga, Ontario, Canada). 50 µg of protein samples were resolved by 10% 
SDS-PAGE (reagents from Bioshop) and immunoblotted with the following antibodies: 
rabbit anti-β-actin (1:5000, Sigma-Aldrich), mouse anti-hLgd1 (1:1000), horseradish 
peroxidase (HRP)-conjugated anti-rabbit IgG  (1:2500, Cell Signaling Technology, 
Beverly, Massachusetts, USA), and HRP-conjugated goat anti-mouse IgG (1:2500, BD 
Pharmigen, San Diego, California, USA). Chemiluminescent signal was detected using a 
LAS3000 imaging system (Fujifilm, Tokyo, Japan). 
 
2.9. T-cell differentiation assay 
E14.5 FL cells harvested from pregnant C57BL/6 mice (obtained from C. Perreault’s 
lab) were prestimulated for 24 hr in DMEM containing 15% foetal-bovine serum, 6 ng/mL 
murine interleukin (IL)-3, 100 ng/mL murine Steel factor, and 10 ng/mL human IL-6 (All 
IL from PeproTech Inc., Rocky Hill, New Jersey, USA). FL cells were then separated into 
6 groups. 5 of the groups were infected with different lentiviruses with 6 μg/mL of 
polybrene for 48 hr. Using a co-culture medium consisting of αMEM, 10% FBS, 10 mM 
HEPES (Invetrogen), 1 mM Sodium Pyruvate (Invetrogen), 50 µg/mL L-gentamycin, 55 
uM 2- beta mercaptanol (Sigma-Aldrich), 100 U/mL penicillin, 100μg/ mL streptomycin, 1 
ng/mL IL-7 (PeproTech Inc.) and 5 ng/mL Flt-3 (PeproTech Inc.), cells were then plated 
onto OP9-GFP expressing cells to stimulate B-cell differentiation or onto OP9-Dl1 to 
stimulate T-cells differentiation. Cells were collected on day 8, 12 and 16 and FACS sorted 
to determine their stage of differentiation.  
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2.10. Flow-Cytometry Analysis and Cell Sorting 
The following antibodies were used: APC anti-mouse CD19, PE-Cy 5 Rat anti-mouse 
CD8a, APC Hamster Anti-mouse TCRβ chain, PE-Cy 7 Rat anti-mouse CD117 (c-Kit), 
APC-Cy 7 Rat anti-mouse CD4, PE anti-mouse CD25 (IL-2R) (Cedarlane Laboratories, 
Hornby, Ontario, Canada). All anti-bodies were from BD PharMingen unless indicated. 
Cells were analyzed on an LSRII flow cytometer with DiVa software and sorted on a three 
laser FACSAria (BD Biosciences). 
  
Results 
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3.1.   Perturbations of dlgd induce stem-cell tumours in the 
larval brain which resembles Notch over expression 
phenotype 
Early characterization of lgd mutant wing discs found that loss of dlgd function 
leads to the ectopic activation of the Notch pathway [40]. Subsequent studies in both the 
wing disc and SOPs indicated that dlgd functions in the early endosome and appears to be 
required for general protein sorting[37-39]. In a recent study, it was found that early 
endocytic protein rab5 is also involved in Notch activation. Overexpression of a dominant 
active form of rab5 (rab5QL) causes accumulation of the Notch receptor in the early 
endosome, overactivation of the Notch signalling pathway and overproliferation of cells in 
the wing disc[299]. To determine if perturbations of the endocytic pathway also affects 
Notch signalling during Drosophila melanogaster brain development, the rab5QL and the 
dlgd08 loss-of-function mutant were expressed in neuroblasts using the insc-Gal4 driver. 
Third-instar larvae were selected, brains isolated and immunostained with anti-Deadpan 
(Dpn, red) to label neuroblasts and anti-Elav (green) to label neurons (Figure 7). Expression 
of both rab5QL and dlgd08 induces a dramatic overproliferation of neuroblasts compared to 
wild-type (WT). These overproliferations appear to originate from the posterior area of the 
brain that contains the 8 asense-negative PAN neuroblasts. When notch is overactivated in 
these cells, it causes uncontrolled division of Ase+ secondary neuroblasts[266] (Figure 7.B). 
This suggests that dlgd08 induces Notch overactivation in PAN neuroblasts. 
 
3.2.   Expression of dlgd08 causes vesicular accumulation 
of Notch in neuroblasts 
Since overexpression of rab5QL causes the accumulation of the Notch receptor in the 
early endosome in the wing disc[299], it was next determined if lgd loss-of-function 
(dlgd08) also results in Notch accumulation in the endocytic compartment. Staining of 
control and dlgd08 mutant third-instar larvae brains for Notch revealed a clear accumulation 
of the Notch receptor in cytoplasmic vesicles (Figure 8.A.). The number of Notch positive  
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Figure 7: Perturbations of the endocytic pathway induce stem-cell tumors in the 
larval brain which resembles Notch over expression phenotype. A) Immunostaining of 
control (top panels), lgd08 mutant (middle panels) and Rab5QL expressing (lower panels) 
third instar larvae brains. Brains were stained with anti-Dpn (red, marking neuroblasts) and 
anti-Elav (green, marking neurons). Note the reduction of the number of differentiated cells 
(neurons) in lgd08 and Rab5QL brains. B) Immunostaining of Nintra expressing third instar 
larvae brains. Figure taken from Bowman et al., Dev Cell 2008[266]. Brains were stained 
with anti-Ase (red, marking PAN-neuroblasts), anti- phalloidin (green, marking actin) and 
anti-Elav (blue, marking neurons). Non-stained cells (cells delineated by actin, but are 
black) are neuroblasts.  
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Figure 8: Vesicular accumulation of Notch. Notch localization in control ( A) top panels) 
or lgd mutant ( B) bottom panels) third instar larvae brains. (Staining: DAPI marks nuclei, 
blue; anti-Notch intracellular domain, green and anti-Dpn, red). B) Quantification of the 
number of Notch positive vesicles in the control and lgd mutant brains. In a 20μm x 20μm 
square, there were 9.5±5 vesicles in the control, and a three-fold increase of vesicles, 
28.3±5 vesicles, in the lgdd08 brain. (n=6)  
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vesicles in the control and dlgd08 mutant brains were quantified (Figure 8.B.). A three-fold 
increase in the number of Notch positive vesicles in dlgd08 mutant neuroblasts was found 
compared to WT neuroblasts (number of vesicles in a 20μm x 20μm square: control=9.5±5, 
dlgd08 =28.3±5, n=6). These results are similar to what was observed in SOPs[38]. The fact 
that Notch accumulates in vesicles and it appears to be overactivated in these endocytic 
mutants, strongly suggest that Notch is activated from within endosomes in the Drosophila 
neuroblasts. 
 
3.3.    Proximal co-localization of hLgd1 with the early 
endosome and hLgd2 with the late endsome  
Very little is known about the mammalian lgd1 and 2. It has been shown that both 
the murine mlgd1 and 2 are able to rescue the dlgd loss-of-function Notch oveactivation 
and wing disc overproliferation phenotypes in Drosophila, thus demonstrating a 
conservation of function between homologs[39]. However, recent publications suggest that 
they may act differently in mammals than in Drosophila[41-44]. In mammals, published 
data shows or strongly suggest that the lgd homologs are not endocytic proteins but 
nuclear[41, 43, 44].Thus it was of interest to determine whethert the human orthologs hlgd1 
and 2 were located in the endocytic compartment or in the nucleus. An endocytosis assay 
was performed. Hela cells were incubated with rhodamine-dextran (red) for 15 or 60 
minutes to label the early and late endosomes, respectively.  Cells were then fixed and 
stained with anti-hLgd1 (blue) and anti-hLdg2 (green) (Figure 9.A.). Both hLgd1 and 
hLdg2 can be found in distinctive punctea located in the cytoplasm, and not in the nucleus 
as previously observed[41, 298]. Though there is some co-localization between all three, 
the endosome, hLgd1 and 2, it appears that hLgd1 and 2 are localized in different 
compartments (Figure 9.A.). hLgd2 does not seem to co-localize with the early endosome. 
There was very little co-localization between the early endosome (red), the early endocytic 
maker early endosome antigen 1 (EEA1, blue) and hLdg2 (green) (Figure 9.B.). However it 
seemed to co-localize with the late endosome. There was a greater co-localization between 
the late endosome (red), the lysosomal marker lysosomal-associated membrane protein 2 
[300] (LAMP2, blue) and hLdg2 (green) (Figure 9.C.). There were also some structures 
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Figure 9: Proximal co-localization of hLgd1 with the early endosome and hLgd2 with 
the late endsome. Hela cells were incubated with rhodamine-labelled dextran for either 15 
minutes, to label the early endosome, or 60 minutes, to label both the early and late 
endosome. A) Immunostaining with anti-hLgd1 (blue) and anti-hLgd2 (green) revealed that 
though there is some co-localization of both proteins (  ) with the early and late 
endosomes (red), the hLgd1 (  ) and hLgd2 ( → ) proteins appear to co-localize with 
different endocytic compartments. B) Immunostaining with anti-hlgd2 (green) and the early 
endocytic marker EEA1 (blue). There was very little co-localization (  ) between hLgd1, 
EEA1 and the early endosome (red). C) Immunostaining with anti-hLgd2 (green) and the 
late endocytic marker LAMP2 (blue). There was co-localization between LAMP2 and 
hLgd2 and the late endosome (    ).There was also some structures where both hLgd2 and 
LAMP2 encircled the endosome (- - -) and structures where the endosome and hLgd2 
ringed LAMP2 vesicles (   ).  
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where both hLgd2 and LAMP2 encircled the endosome and structures where the endosome 
and hLgd2 ringed LAMP2 vesicles (Figure 9.C.), which are representative of lysomic 
vesicles[301]. These results suggest that hLgd1 is associated with the early endosome while 
hLgd2 is associated with the later endosome and lysosome. 
 
3.4.   Lentivirus production and knockdown of the murine 
mlgd1 and mlgd2 mRNA and protein levels 
The next aim of the study was to determine if the mammalian Lgd also regulates 
Notch signaling in mammals. One of the best studied Notch dependent events is the 
differentiation of the T cell lineage. Notch signalling has been demonstrated to play 
essential roles at several stages of T cell development, differentiation and function, 
including during T cell immune responses[207-209]. Thus to best study the effects of 
mammalian lgd, it was decided to knockdown the murine mlgd1 and 2 in hematopoietic 
stem cells (HSCs) and observe how it affects T cell differentiation using a ex vivo OP9 co-
culture T cell differentiation assay[215]. Primary cell lines and stem cells, which are long-
term slow dividing cells, have a very low transfection efficiency since most transfection 
methods require the cells to be in the S/G(2)/M phase to incorporate the plasmid into the 
genome of the cell. Lentiviruses have been shown to transduce both proliferating and non-
proliferating cells, and allows for long term stable expression of the incorporated 
transgene[302].  Improved safety features, such as self inactivating long terminal repeats 
(SIN-LTRs) and minimal split packaging designs[303], makes the SIN-lentiviruses the best 
candidate for the delivery and integration of short hairpin RNA (shRNA) against mlgd1 and 
2 into HSCs.  
Five shRNA sequences specific to the mlgd1 and mlgd2 were designed and cloned 
into lentiviruses along with an off-target shRNA sequence to be use as a control. To test 
which shRNA sequence most efficiently knocks down the target genes and proteins, the 
murine fibroblastic cell line NIH-3T3 was infected at a multiplicity of infection (MOI) of 
25 with lentivirus expressing shRNA sequences against mlgd1, mlgd2 and the off-target for 
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Figure 10: Down regulation of the mLgd1 protein and the mlgd2 mRNA after stable 
expression of ShRNA against mldg1 and mlgd2 in NIH-3T3 cells.  NIH-3T3 cells were 
infected (MOI 25) with lentivirus expressing shRNA against mlgd1, mlgd2 and an off-
target sequence. Cells were treated for 4 days with puromycin (1µg/mL) to select cells 
expressing the shRNAs. Protein and mRNA was extracted after 7 and 10 days of the initial 
infection. Western blot of 50µg of total protein extracts isolated after 7 days (A) and 10 
days (B) of incubation were probed with anti-hlgd1 and anti-actin. There appears to be a 
30% decrease in the mlgd1 protein after 10 days of incubation. C) qPCR for the mlgd2 
gene from total RNA extracted after 10 days of incubation. shRNA 3, 4 and 5 against 
mlgd2 decrease the expression of the mlgd2 gene by 70-80%. The shRNA4 appear to be the 
best candidate because it affects the mlgd2 gene only.  
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36 hours. Cells were then challenged with puromycine (1 µg/ml) for 4 days to selected cells 
that incorporated that the shRNA vectors. RNA and proteins were extracted at 7 and 10 
days after initial infection.  
Protein levels of mLgd1 were determined by western blot using a commercially 
available antibody against hLgd1 (Figure 10.A. & B.). There were no commercially 
available Lgd anti-bodies that specifically recognized the murine isoforms. A commercially 
available antibody that against hLgd2 was also tested however, it did not detect the murine 
form of mLgd2. Though mLgd1 is predicted to have a mass of 104 KDa, the anti-hLgd1 
can detect the murine mLgd1 as either a single band or double band at approximately 125 
KDa (Figure 10.A. & B.). This difference between the predicted molecular mass and the 
one observed is also seen when the antibody is used to detect the human hLgd1 isoform[42, 
295]. Since very little is known on how the Lgd protein functions and how they are 
activated, it is possible that this difference in size could be due to post-translational 
modification such as phosphorylation, glycosylation, etc. Preliminary experiments suggest 
that a minimum of 10 days is required after initial lentiviral infection to observe a decrease 
in mLgd1 protein levels by shRNAs (Figure 10.B.). By calculating pixel density and 
normalizing it to actin levels, there appears to be approximately 30% decrease in mlgd1 
protein levels. However, due to unequal protein loading and saturation of the actin signal, 
these results must be taken with caution and must be validated by further experiments.  
To evaluate the effects of the shRNAs on the expression of the mlgd2 gene, qPCR 
analysis on extracted total RNA from NIH-3T3 cell after 10 days of the initial lentivirus 
infection was perform for the mlgd1 and mlgd2 genes (Figure 10.C.). mlgd1 and mlgd2 
expression levels were normalized to three different control housekeeping genes: β-actin, 
hypoxanthine guanine phosphoribosyl transferase (Hprt) and TATA box binding protein 
(Tbp). The shRNA against mlgd1 and 2 appeared to have an effect on the expression of the 
β-actin gene, so it was not used as a control (data not shown).  Though the data is not 
shown, similar results were obtained with the Tbp control gene as with Hprt control gene. 
The shRNA 3, 4 and 5 against mlgd2 decrease the expression of the mlgd2 gene by 70-80% 
(Figure 10.C.). However, mlgd2 shRNA4 appear to be the best candidate because it 
affected the mLgd2 gene only (Figure 10.C.). The effects of the mlgd1 shRNAs on the 
expression of the mLgd1 gene were also evaluated by qPRC however, the results were 
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inconsistent. This inconsistency could be due to off target gene amplification due to 
inadequate primer selection or poor RNA quality. 
 
3.5.   mlgd1 and mlgd2 modulates T-cell lineage 
development, most-likely due to Notch activation 
T cell development can be studied in vitro using a two-dimensional cultures system 
where hematopoietic progenitors are exposed to Delta-like ligands that are expressed by 
cells[212-214]. In this study, the murine bone marrow stromal cell line, OP9, was used in a 
co-culture to support lymphoid lineage differentiation. E14.5 Foetal liver cells were 
harvested from pregnant C57BL/6 mice and used as a source of hematopoietic progenitors. 
Foetal liver cells were first expanded and prestimulated with cytokine for 24 hours and then 
infected for 48 hours with mlgd1, mlgd2 or off-target shRNA lentiviruses (MOI 10). The 
foetal liver cells were co-cultured on top of OP9 cells transduced with the Notch ligand 
Delta-like-1 (OP9-Dl1) cells to supports T lymphopoiesis, as well as onto OP9 cells 
transduced with GFP (OP9-GFP) to supports B lymphopoiesis[215]. Cells were collected 
on day 8, 12 and 16 and FACS sorted to determine their stage of differentiation (Figure 11).  
It is well established that overexpression of Notch1 in common lymphoid precursors 
drive T cell development at expense of natural killer, B lymphoid cells[206], and the 
myeloid lineage[304]. Under co-culture OP9-GFP B lymphopoiesis condition, cells 
expressing either the mlgd1 or mlgd2 shRNAs supported the maintenance of early T-cell 
progenitors (ETPs) compared to off-target control (Bottom panel, Figure 10.A.). Cells co-
cultured on OP9-GFP were not collected on day 12 of co-culture due to a large number of 
dead cells observed when FACS analyzed on day 8. Cells were kept in culture and only 
sorted on day 16. Knocked down of the mlgd1 and mlgd2 genes had no overall affect on B 
cell development, which was the opposite of what was expected (Bottom panel, Figure 
10.C.). This may be due to an inefficient overactivation of the Notch pathway.  
After 8 days of co-culture, foetal liver cells expressing mlgd1 shRNA 2 and mlgd2 
shRNAs 4 & 5 co-cultured under OP9-Dl1 T lymphopoiesis condition, also supported the 
maintenance and proliferation of early T-cell progenitors (ETPs) compared to off-target and  
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Figure 11:  shRNA knockdown of mlgd1 and mlgd2 in foetal liver cells speeds up 
development of progenitors into the T-cell lineage, but causes a block at DN3 stage. E14.5 
Foetal liver cells were harvested from pregnant C57BL/6 mice, prestimulated for 24 hr and then 
infected for 48 hr with mLgd1, mLgd2 or off-target shRNA lentiviruses (MOI 10). Cells were 
then plated onto OP9-GFP expressing cells to stimulate B-cell differentiation or onto OP9-Dl1 
to stimulate T-cells differentiation. Cells were collected on day 8 (A), 12 (B) and 16 (C) and 
FACS sorted to determine their stage of differentiation. Knockdown of mLgd1 and 2 did not 
have any effect on B-cell differentiation (A and C bottom panels). Knockdown of mLgd1 and 2 
accelerated foetal liver cell differentiation into the T-cell lineage (A top panel, B), however 
these cells were blocked at the DN3 stage (C, top panel). A student’s T-test was performed on 
the data collected. ETP: early T-cell progenitor, DN: double negative, SP: single positive, DP: 
double positive 
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non-treated controls (Top panel, Figure 11.A.). Cells expressing the mlgd1 and 2 shRNAs 
had a significant larger DN2 population levels compared non-treated control. A significant 
higher DN2 population level was also observed for cells expressing mlgd1 shRNA 2 and 
mlgd2 shRNAs 4 & 5 compared to the off-target shRNA control (Top panel, Figure 11.A.). 
However, these cells had a significantly lower DN3 population compared to off-target and 
non-treated controls as well. By day 12 of OP9-Dl1 co-culture, the DN3 population was 
significantly higher and the CD4+CD8+ double positive (DP) population level was 
significantly lower in cells expressing the mlgd1 and mlgd2 shRNAs compared to both the 
off-target shRNA and non-treated control cells (Figure 11.B.). This indicates that down 
regulation of mlgd1 and mlgd2 causes an accelerated differentiation of hematopoietic stem 
cell into the T lymphopoiesis lineage. However at 16 of OP9-Dl1 co-culture, the DN3 
population level of the non-treated cells was similar to those of the cells expressing the 
mlgd1 and mlgd2 shRNAs (Top panel, Figure 11.C.). Though one would expect the 
CD4+CD8+ DP population levels of the cells expressing the mlgd1 and mlgd2 shRNAs to 
be greater than those of the non-treated cells, they are actually significantly lower (Top 
panel, Figure 11.C.). This suggests that downregulation of mlgd1 and mlgd2 causes a block 
in the DN3 to CD4+CD8+ DP transition. The overall different populations’ levels of the 
cells expressing the off-target shRNA were significantly lower than the other groups (Top 
panel, Figure 11.C.). When the sample was FACS sorted, it had the lowest total population 
events collected and appeared to have higher incidence of cellular death compared to the 
other groups. An error in experimental manipulation of the off-target shRNA expressing 
cells on day 16 of OP9-Dl1 co-culture most-likely occured, thus it was not used for 
comparison with the other groups. Overall the fact that down regulation of mlgd1 and 
mlgd2 causes an accelerated differentiation of hematopoietic stem cell into the T 
lymphopoiesis lineage and that there was a block in block in the DN3 to CD4+CD8+ DP 
transition, suggests that Notch is overactivated in these cells[203, 232].  
 
 
   
  
Discussion 
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Notch signalling is essential to many developmental processes and has been shown to 
regulate stem cell self-renewal, cell proliferation, cell differentiation and apoptosis. Loss of 
function of various components of the Notch signalling pathway is known to be the cause 
of some inherited diseases[13] and different types of cancers[14, 15]. Thanks to studies 
performed in the Drosophila model system, it was revealed that endocytosis plays a critical 
role in the regulation of Notch activation and processing of its ligands.  
The Drosophila gene lethal giant discs (dlgd), named after its loss of function 
phenotype, has been shown to play a role in the regulation of the Notch signalling. 
Mutations in this gene cause overgrowth of the imaginal discs through a perturbation in 
Notch endocytosis[37-40]. Though dLgd has been characterized to function in the 
endocytic pathway, its precise function is unknown. Even less is known of the mammalian 
lgd1 and 2. In a Drosophila loss-of-function experiment, both the murine mlgd1 and 2 
orthologs were able to rescue the dlgd loss-of-function phenotype, thus demonstrating a 
conservation of function between homologs[39]. However, recent publications suggest that 
they may act differently in mammals than in Drosophila[41-44]. In mammals, published 
data shows or strongly suggest that the Lgd homologs are not endocytic proteins but 
nuclear[41, 43, 44]. 
Notch signalling is well known to play a role in regulating the maintenance of 
neuronal stem cells and cell fate choice in the central nervous system of both Drosophila 
and mammals. In Drosophila experiments, loss-of-function Notch causes neuroblast to 
differentiate into neural cells[259, 260], while overactivation of Notch pathway causes 
overperliferation and loss of differentiation of neuroblasts [266]. Recent studies have 
implicated the two human Drosophila lgd orthologs, hlgd1 and hlgd2, in brain development 
as well [295, 296]. This was why the Drosophila neuroblast was chosen as model system in 
the first part of this study to validate that dLgd is implicated in Notch signalling. We 
demonstrated that dlgd08 mutants induced a dramatic overproliferation of neuroblasts 
(Figure 7.A.) and an accumulation of the Notch receptor in vesicular structures (Figure 8) 
compared to wild-type (WT). This was similar to the rab5QL mutants (Figure 7.A.) which 
have been shown to cause an accumulation of the Notch receptor in the early endosome, 
overactivation of the Notch signalling pathway and overproliferation of cells in the wing 
disc[299]. The dlgd08 mutant Drosophila phenotype appears to be caused by an 
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overactivation of Notch due to its accumulation in vesicles, suggests that Notch is activated 
from within endosomes in the Drosophila neuroblasts. Taking into account these 
observations, and that Notch is implicated neuronal differentiation [270] in mammals, 
indicates that mutations of hLgd in NSMR patients may also cause an accumulation of the 
Notch receptor in the endosome and overactivation of the Notch pathway in the patient’s 
neuronal stem cells.  
Very little is known about the mammalian lgd1 and 2. It has been shown that both the 
murine mlgd1 and 2 are able to rescue the dlgd loss-of-function Notch overactivation and 
wing disc overproliferation phenotypes in Drosophila, thus demonstrating a conservation of 
function between homologs[39]. Studies performed in the murine, rat and human brain or 
neuronal cells have shown that the mammalian lgd1 and 2 homologs function as a 
transcription regulator for 5-HT1A serotonin receptor and are located in the nucleus[41, 43, 
44, 298, 305]. Thus it was of interest to determine whether the human orthologs hlgd1 and 
2 were located in the endocytic compartment or in the nucleus. Immunohistochemistry was 
performed on the human cervical immortal cell line cells, Hela. hLgd-1 and 2 were found in 
distinctive punctea located in the cytoplasm (Figure 9.A.), when cells stained with  both 
anti-hLgd1 and anti-hLdg2, and not in the nucleus as previously observed[41, 298]. Though 
there is some co-localization between all three, the endosome, hlgd1 and 2, it appears that 
hlgd1 and 2 are localized in different compartments (Figure 9.A.). Co-localization studies 
with hLdg2 and the early endosome marker EEA1 (Figure 9.B) or the late endosome 
LAMP2 (Figure 9.C.) suggest that hLgd2 is associated with the late endosome and 
lysosome while hLgd1 is associated with the early endosome. However further 
investigation is required to pinpoint the exact locations of the hLgd proteins in the 
cytoplasm. Studies in Drosophila have demonstrated that dLgd is located in the endocytic 
pathway after presenilin and hrs, but before the ESCRT complex[37, 39, 40].  Thus, it 
would be of interest to continue the immunohistochemistry and compare the location of 
dLgd, hLgd1 and hLgd2 to a panel of known endocytic proteins. 
The next aim of the study was to determine if mammalian lgd1 and 2 also regulate 
Notch signaling in mammals. One of the most studied Notch dependent system is the 
differentiation of the T cell lineage. Thus to best study the effects of mammalian lgd, it was 
decided to knockdown the murine mlgd1 and 2 in hematopoietic stem cells (HSCs) and 
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observe how it affects T cell differentiation using an ex vivo T cell differentiation 
assay[215]. To test which shRNA sequence most efficiently knocks down the target genes 
and proteins, NIH-3T3 cells were infected with the various lentiviruses. Total protein and 
RNA were extracted from these cells and the mLgd 1 and 2 protein and RNA levels were 
determined by western blot and qPRC, respectively (Figure 10).  
Protein levels of mLgd1 and 2 were detected using commercially available antibodies 
against the hLgds, since there were no murine mLgd1 and 2 antibodies available. The 
antibody against hLgd2 did not detect the murine form of mLgd2. Preliminary experiments 
suggest that a minimum of 10 days is required after initial lentiviral infection to observe a 
decrease in mLgd1 protein levels due to shRNA (Figure 10.B.). By calculating pixel 
density and normalizing it to actin levels, there appears to be approximately 30% decrease 
in mlgd1 protein levels. However, due to unequal protein loading and saturation of the actin 
signal, these results must be taken with caution and must be validated by further 
experiments. It would be of interest to create tagged mlgd1 and 2 clones in order to better 
identify these protein in either immunohistochemistry experiments or by western blots 
since there are no a commercially available murine antibodies for the mLgd proteins. It 
would also be advisable to create homemade mLgd1 and mLgd2 antibodies. 
The RNA levels were evaluated for the mlgd1 and mlgd2 genes by qPCR (Figure 
10.C.). The mlgd2 shRNA 3, 4 and 5 decrease the expression of the mlgd2 gene by 70-80% 
(Figure 10.C.). However, mlgd2 shRNA4 appear to be the best candidate because it affects 
the mlgd2 gene only (Figure 10.C.). The effects of the mlgd1 shRNAs on the expression of 
the mlgd1 gene were also evaluated by qPRC however, the results were inconsistent. This 
inconsistency could be due to off target gene amplification due to inadequate primer 
selection or poor RNA quality. New primers need to be designed and RNA quality should 
be check prior to reversed transcription. 
T cell development was studied using the ex vitro OP9-Dl1 two-dimensional cultures 
system[212-214]. E14.5 Foetal liver cells were harvested from pregnant C57BL/6 mice and 
used as a source of hematopoietic progenitors. Foetal liver cells were first expended and pre 
stimulated with cytokine for 24 hours and then infected for 48 hr with mlgd1, mlgd2 or 
control shRNA lentiviruses. Cytokine stimulation of the quiescent hematopoietic 
progenitors prior to lentiviral transduction induces cell cycling which is believed to 
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improve the transduction efficiency of reconstituting stem cells and help induce 
differentiation of HSCs[306, 307].  
When foetal liver cells were co-culture onto OP9-GFP, favouring B lymphopoiesis, 
downregulation of both mlgd1 and mlgd2 by shRNAs supported the maintenance of early 
T-cell progenitors (ETPs) compared to off-target control (Bottom panel, Figure 10.A.). 
Notch signalling is known to be essential for the generation of foetal hematopoietic stem 
cells (HSCs) [210, 211], thus this suggests that down regulation of mlgd1 and 2 may be 
activating the Notch pathway. However the mlgd1 and mlgd2 shRNAs had no overall affect 
on B cell development, which was the opposite of what was expected (Bottom panel, 
Figure 10.C.). This may be due to inefficient overactivation of the Notch pathway.  
Downregulation of both mlgd1 and mlgd2 also induced proliferation and help 
maintain ETP population of foetal liver cells co-culture onto OP9-Dll1, favouring T 
lymphopoiesis, compared to off-target and non-treated controls (Top panel, Figure 11.A.) 
In addition, it also caused an accelerated differentiation of hematopoietic stem cell into the 
T lymphopoiesis lineage. There was a greater population of DN2 cells at day 8 of co-
culture (Top panel, Figure 11.A.) and of DN3 population at day 12 (Figure 11.B) compared 
to off-target shRNA and non-treated control. The exact role Notch signalling in ETP-DN2 
transition is ambiguous, however Notch signalling is required for the maintenance of CD25 
expression in DN2 and DN3 cells and the survival of DN2, DN3 and DN4 cells[220, 221]. 
Thus overactivation of the Notch signalling could explain this accelerated differentiation. 
At 16 days of OP9-Dl1 co-culture, the DN3 population level of the non-treated cells 
is similar to those of the cells expressing the mlgd1 and mlgd2 shRNAs (Top panel, Figure 
11.C.). However, one would expect that the CD4+CD8+ DP population levels of the mlgd1 
and mlgd2 shRNAs expressing cells would be greater than those of the non-treated cells 
since the DN3 levels were much greater at day 12. This suggests that downregulation of 
mlgd1 and mlgd2 causes a block in the DN3 to CD4+CD8+ DP transition. This sort of 
phenotype is also observe when Presenilin1/2 is downregulated[231]. Notch signalling is 
maintained in mice until the β selection or pre-TCR checkpoint and is rapidly 
downregulated afterwards[222, 223]. Deletion of Presenilin1 is initiated at the DN2-DN3 
stage, thus occurs prior to TCRβ selection[231]. This severely impacts DP thymocyte 
number because the cells cannot mature past the DN3 stage[203, 232]. The deletion of 
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genes that impact Notch signalling, which is induced after the DP stage or TCRβ selection, 
such as deletion of the CSL gene and mastermind, generate normal numbers of DP 
thymocytes[229, 230], indicating that Notch signalling is down regulated later, most likely 
after TCRβ selection. This suggests that in the case of mlgd1 and mlgd2 downregulation, 
Notch is overactivated in the thymocytes prior to pre-TCRβ selection. However, it cannot 
be concluded that deregulation of Notch signalling is the sole reason why downregulation 
of mlgd1 and mlgd2 causes an accelerated T cell differentiation in the foetal liver cells. In 
Drosophila mutations of dlgd causes an accumulation of Notch in enlarges early endosome 
punctas, ubiquitinated protein and the EGF receptor as well, indicating that dlgd is required 
for general protein sorting[38, 39]. This suggests that deregulation of mlgd1 and 2 in HSCs 
may trigger general defects in endocytosis and thus cause perturbation in other signalling 
pathways important in the T cell differentiation process. Further investigation is required to 
validate that downregulation of mlgd1 and mlgd2 causes accelerated T cell differentiation 
in the foetal liver cells is due to Notch overactivation. The T cell differentiation assay needs 
to be redone with proper Notch controls such as, over and down expression of the Notch 
receptor and target genes. Also over and down expression of known endocytic protein that 
upregulate Notch signalling or have no affects. 
Currently, to further analyze the role of mammalian Lgd homologs, ES-cells knock-
out for mLgd1 and 2 were ordered from the KOMP consortium in order to generate 
conditional knockout (KO) mice. If the null mice are lethal, various CRE lines will be used 
to generate tissues-specific nulls, such as the CRE lines Nestin-Cre[308] for the brain and 
Lck-Cre[309] and Vav-Cre[310] for the immune system.  Initial analysis of the morphology 
of null mice for either one or the combination of both mLgd will first focus on brain 
development since Notch plays a critical role in brain development and the implications of 
hLgd1 and 2 in mental retardation[295, 296]. Then the components of the peripheral blood, 
such as the proportion of T- and B-cell, will be examined since Notch signalling is essential 
for T-cell differentiation[206].  
From the generated Lgd null mouse, mouse embryonic fibroblasts (MEFs) cell lines 
for mLgd1-/- MEFs, mLgl2-/- MEFs and double KO MEFs would also be established in 
order to compare endosomal morphology and function to that of wild type MEFs.   
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